Pioneering API-Distribution since 1963
High-quality APIs with value added services
Best value based on better access, better quality, and better supply of APIs and ingredients.
From manufacturers via customers to the patients at the end of the supply chain, TIEFENBACHER API + INGREDIENTS is more than just a name. It is our purpose to deliver better healthcare through safe and reliable API-distribution to Europe. We provide a full and complementary range of high-quality raw materials and value-added services throughout the entire life cycle of pharmaceutical products. Established as the world’s first exclusive API distributor in 1963, we are a pioneer in the supply of the European pharmaceutical industry with the finest APIs of distinguished manufacturers around the globe. Today we distribute our portfolio of 600+ APIs (human + animal health) to more than 250 customers in more than 30 European countries. We go beyond API-distribution to provide best-in-class-solutions to make business faster, simpler, and more efficient.
Thereby we are daily driven by our commitment that every API shipment is delivering on our best value seal: offering our customers a BETTER ACCESS, a BETTER QUALITY, and a BETTER SUPPLY of APIs.
Quality and maximum safety throughout the entire API-Distribution
High-quality raw materials for safe, reliable pharmaceuticals
Our business goes far beyond the sheer distribution of raw materials (human +veterinary). We stand for reliability, the highest standards of safety and quality, and a forward-looking approach.
TIEFENBACHER API + INGREDIENTS adhers to all relevant pharmaceutical industry standards and guidelines from start to finish: from API-sourcing to delivering the right product to the right place at the right time. Quality, safety, and efficacy are our ultimate tasks. Therefore, we incorporate quality in every element of the API-supply chain – and each year our APIs positively impact millions of patients’ lives. Our API-products are high-quality, manufactured according to GMP (Good Manufacturing Practices) and distributed following GDP (Good Distribution Practices).
600+
APIs (human + veterinary)
>
250+
European customers
>
100+
audits
>
130+
manufacturers
>
600+
APIs (Human + Animal)
>
250+
European customers
>
100+
audits
>
130+
manufacturers
>
100%
value chain distribution
>
own GMP-warehouse
>
quality assurance (QA) + regulatory affairs (RA)
>
100%
after sales service
>
100%
Value chain Distribution
>
Own GMP-warehouse
>
Quality assurance (QA) + Regulatory Affairs (RA)
>
100%
After Sales Service
>
High-quality APIs + Ingredients for Human and Veterinary: in all fourteen ATC therapy groups
Our API-Products: Reliable, fast, and with full regulatory support towards GMP + GDP guidelines
We, at TIEFENBACHER API + INGREDIENTS, offer an extensive portfolio of APIs + ingredients in all fourteen main ATC-Groups – in addition we have the permission to handle narcotics according to § 3 BtmG.
High-quality is essential in the production of safe, reliable pharmaceuticals. We offer a comprehensive range of raw materials (Human + Veterinary) and controlled substances with the highest demand concerning quality and security. We cover both “super sales” molecules and niche molecules or specialized therapies. Please find a selection of our raw materials (human & veterinary) with the highest demand concerning quality and security below. Our GMP and GDP certificates attest to our high level of quality and safety along the entire value chain. If you can’t find the API-products (R&D and commercial) you’re looking for, please contact us by filling out the contact form below on this webpage, or please directly send an email to info-api@tiefenbacher.com.
| Product name | ATC | CAS No. | Category | Commercial API / R & D |
|---|---|---|---|---|
| 5-Fluorocytosine | D Dermatologicals J Antiifectives for Systemic Use | 2022-85-7 | Human | R & D |
| Abacavir | J Antiinfectives for Systemic Use | 136470-78-5 | Human | R & D |
| Abaloparatide Acetate | H Systemic Hormonal Preperations, excl. Sex Hormones and Insulins | 247062-33-5 | Human | R & D |
| Abemaciclib | L Antineoplastic and Immunomodulating Agents | 1231929-97-7 | Human | R & D |
| Abiraterone | L Antineoplastic and Immunomodulating Agents | 154229-19-3 | Human | R & D |
| Abiraterone Acetate | L Antineoplastic and Immunomodulating Agents | 154229-18-2 | Human | R & D |
| Abrocitinib | D Dermatologicals | 1622902-68-4 | Human | R & D |
| Acalabrutinib | L Antineoplastic and Immunomodulating Agents | 1420477-60-6 | Human | R & D |
| Acamprosate | N Nervous System | 77337-76-9 | Human | R & D |
| Aclidinium Br | R Respiratory System | 320345-99-1 | Human | R & D |
| Acyclovir | J Antiinfectives for Systemic Use | 59277-89-3 | Human | R & D |
| Adrenaline Bitartrate | C Cardiovascular System | 51-42-3 | Human | R & D |
| Afatinib | L Antineoplastic and Immunomodulating Agents | 850140-72-6 | Human | R & D |
| Afatinib Dimaleate | L Antineoplastic and Immunomodulating Agents | 850140-73-7 | Human | R & D |
| Afoxolaner | P Antiparasitic Products, Insecticides and Repellents | 1093861-60-9 | Vet | R & D |
| Agomelatine | N Nervous System | 138112-76-2 | Human | R & D |
| Albendazole | P Antiparasitic Products, Insecticides and Repellents | 54965-21-8 | Human | R & D |
| Alectinib HCl | L Antineoplastic and Immunomodulating Agents | 1256589-74-8 | Human | R & D |
| Alizapride | A Alimentary Tract and Metabolism | 59338-93-1 | Human | R & D |
| Allopurinol | M Musculo-Sekeletal System | 315-30-0 | Human | R & D |
| Alogliptin | A Alimentary Tract and Metabolism | 850649-61-5 | Human | R & D |
| Alogliptin Benzoate | A Alimentary Tract and Metabolism | 850649-62-6 | Human | R & D |
| Alpelisib | L Antineoplastic and Immunomodulating Agents | 1217486-61-7 | Human | R & D |
| Amifampridin Phosphate | N Nervous System | 446254-47-3 | Human | R & D |
| Amiodarone HCl | C Cardiovascular System | 19774-82-4 | Human | R & D |
| Amlodipin Besylate | C Cardiovascular System | 111470-99-6 | Human | R & D |
| Amlodipine | C Cardiovascular System | 88150-42-9 | Human | R & D |
| Ansofaxine HCl | n.a. | 916918-84-8 | Human | R & D |
| Apabetalone | n.a. | 1044870-39-4 | Human | R & D |
| Apalutamide | L Antineoplastic and Immunomodulating Agents | 956104-40-8 | Human | R & D |
| Apixaban | B Blood and Blood Forming Organs | 503612-47-3 | Human | R & D |
| Apixaban Amorphous | B Blood and Blood forming Organs | 503612-47-3 | Human | R & D |
| Apremilast | L Antineoplastic and Immunomodulating Agents | 608141-41-9 | Human | R & D |
| Aprepitant | A Alimentary Tract and Metabolism | 170729-80-3 | Human | R & D |
| Arformoterol Tartrate | n.a. | 200815-49-2 | Human | R & D |
| Aripiprazole H2O | N Nervous System | 851220-85-4 | Human | R & D |
| Aripiprazole Lauroxil | N Nervous System | 1259305-29-7 | Human | R & D |
| Armodafinil | N Nervous System | 112111-43-0 | Human | R & D |
| Atazanavir | J Antiinfectives for Systemic Use | 198904-31-3 | Human | R & D |
| Atenolol | C Cardiovascular System | 29122-68-7 | Human | R & D |
| Atogepant | N Nervous System | 1374248-81-3 | Human | R & D |
| Atorvastatin | C Cardiovascular System | 134523-00-5 | Human | R & D |
| Atosiban Acetate | G Genito Urinary System and Sex Hormones | 914453-95-5 | Human | R & D |
| Atovaquone | P Antiparasitic Products, Insecticides and Repellents | 95233-18-4 | Human | R & D |
| Avanafil | G Genito Urinary System and Sex Hormones | 330784-47-9 | Human | R & D |
| Avatrombopag | B Blood and Blood forming Organs | 570406-98-3 | Human | R & D |
| Avatrombopag Maleate | B Blood and Blood forming Organs | 677007-74-8 | Human | R & D |
| Axitinib | L Antineoplastic and Immunomodulating Agents | 319460-85-0 | Human | R & D |
| Axitinib Form IV | L Antineoplastic and Immunomodulating Agents | 319460-85-0 | Human | R & D |
| Azacitidine | L Antineoplastic and Immunomodulating Agents | 320-67-2 | Human | R & D |
| Azelnidipine | n.a. | 123524-52-7 | Human | R & D |
| Azilsartan Base | C Cardiovascular System | 147403-03-0 | Human | R & D |
| Azilsartan Kamedoxomil | C Cardiovascular System | 863031-21-4 | Human | R & D |
| Azilsartan Kamedoxomil Form I | C Cardiovascular System | 863031-21-4 | Human | R & D |
| Azilsartan Medoxomil Monopotassium | C Cardiovascular System | 863031-21-4 | Human | R & D |
| Azilsartan Medoxomil Potassium | C Cardiovascular System | 863031-24-7 | Human | R & D |
| Balovaptan | n.a. | 1228088-30-9 | Human | R & D |
| Baloxavir | J Antiinfectives for Systemic Use | 1985605-59-1 | Human | R & D |
| Baloxavir Marboxil | J Antiinfectives for Systemic Use | 1985606-14-1 | Human | R & D |
| Bardoxolone Methyl | n.a. | 218600-53-4 | Human | R & D |
| Baricitinib | L Antineoplastic and Immunomodulating Agents | 1187594-09-7 | Human | R & D |
| Baricitinib Citrate | L Antineoplastic and Immunomodulating Agents | 1187594-09-7 | Human | R & D |
| Bazedoxifene | G Genito Urinary System and Sex Hormones | 198481-32-2 | Human | R & D |
| Bazedoxifene Acetate | G Genito Urinary System and Sex Hormones | 198481-33-3 | Human | R & D |
| Bedaquiline Fumarate | J Antiinfectives for Systemic Use | 845533-86-0 | Human | R & D |
| Belumosudil | L Antineoplastic and Immunomodulating Agents | 911417-87-3 | Human | R & D |
| Belumosudil Mesylate | L Antineoplastic and Immunomodulating Agents | 2109704-99-4 | Human | R & D |
| Bempedoic Acid | C Cardiovascular System | 738606-46-7 | Human | R & D |
| Bendamustine HCl | L Antineoplastic and Immunomodulating Agents | 3543-75-7 | Human | R & D |
| Benfotiamine | A Alimentary Tract and Metabolism | 22457-89-2 | Human | R & D |
| Bensarazide | n.a. | 322-35-0 | Human | R & D |
| Berotralstat HCl | B Blood and Blood Forming Organs | 1809010-52-3 | Human | R & D |
| Betrixaban | B Blood and Blood Forming Organs | 330942-05-7 | Human | R & D |
| Bictegravir | J Antiinfectives for Systemic Use | 1611493-60-7 | Human | R & D |
| Bictegravir Sodium | J Antiinfectives for Systemic Use | 1611493-60-7 | Human | R & D |
| Bilastine | R Respiratory System S Sensory Organs | 202189-78-4 | Human | R & D |
| Binimetinib | L Antineoplastic and Immunomodulating Agents | 606143-89-9 | Human | R & D |
| Bisoprolol | C Cardiovascular System | 66722-44-9 | Human | R & D |
| Blonanserin | n.a. | 132810-10-7 | Human | R & D |
| Bompedoic Acid | C Cardiovascular System | 738606-46-7 | Human | R & D |
| Bortezomib | L Antineoplastic and Immunomodulating Agents | 179324-69-7 | Human | R & D |
| Bosutinib | L Antineoplastic and Immunomodulating Agents | 380843-75-4 | Human | R & D |
| Bosutinib Form I | L Antineoplastic and Immunomodulating Agents | 380843-75-4 | Human | R & D |
| Bosutinib H2O | L Antineoplastic and Immunomodulating Agents | 380843-75-4 | Human | R & D |
| Bremelanotide | G Genito Urinary System and Sex Hormones | 189691-06-3 | Human | R & D |
| Brexanolone | N Nervous System | 516-54-1 | Human | R & D |
| Brexpiprazole | N Nervous System | 913611-97-9 | Human | R & D |
| Brigatinib | L Antineoplastic and Immunomodulating Agents | 1197953-54-0 | Human | R & D |
| Brimonidine | D Dermatologicals | 59803-98-4 | Human | R & D |
| Brimonidine Tartarate | S Sensory Organs | 70359-46-5 | Human | R & D |
| Brinzolamide | S Sensory Organs | 138890-62-7 | Human | R & D |
| Brivaracetam | N Nervous System | 357336-20-0 | Human | R & D |
| Bupivacaine | N Nervous System | 2180-92-9 | Human | R & D |
| Buprenorphine HCl | N Nervous System | 53152-21-9 | Human | R & D |
| Bupropion HCl | N Nervous System | 31677-93-7 | Human | R & D |
| Buspirone HCl | N Nervous System | 33386-08-2 | Human | R & D |
| Busulfan | L Antineoplastic and Immunomodulating Agents | 55-98-1 | Human | R & D |
| Cabazitaxel | L Antineoplastic and Immunomodulating Agents | 183133-96-2 | Human | R & D |
| Cabotegravir | J Antiinfectives for Systemic Use | 1051375-10-0 | Human | R & D |
| Cabotegravir Sodium | J Antiinfectives for Systemic Use | 1051375-13-3 | Human | R & D |
| Cabozantinib | L Antineoplastic and Immunomodulating Agents | 849217-68-1 | Human | R & D |
| Cabozantinib Malate | L Antineoplastic and Immunomodulating Agents | 1140909-48-3 | Human | R & D |
| Cabozantinib S-Malate | L Antineoplastic and Immunomodulating Agents | 1140909-48-3 | Human | R & D |
| Cadazolid | n.a. | 1025097-10-2 | Human | R & D |
| Camostat | B Blood and Blood Forming Organs | 59721-28-7 | Human | R & D |
| Canagliflozin | A Alimentary Tract and Metabolism | 842133-18-0 | Human | R & D |
| Canagliflozin 0.5H2O | A Alimentary Tract and Metabolism | 928672-86-0 | Human | R & D |
| Cangrelor Tetrasodium | B Blood and Blood Forming Organs | 163706-36-3 | Human | R & D |
| Cannabidiol | N Nervous System | 13956-29-1 | Human | R & D |
| Cantharidin | n.a. | 56-25-7 | Human | R & D |
| Capecitabine | L Antineoplastic and Immunomodulating Agents | 154361-50-9 | Human | R & D |
| Capmatinib | L Antineoplastic and Immunomodulating Agents | 1029712-80-8 | Human | R & D |
| Carbozantinib S-Malate | L Antineoplastic and Immunomodulating Agents | 163706-36-3 | Human | R & D |
| Carfilzomib | L Antineoplastic and Immunomodulating Agents | 868540-17-4 | Human | R & D |
| Cariprazine | N Nervous System | 839712-12-8 | Human | R & D |
| Carmustine | L Antineoplastic and Immunomodulating Agents | 154-93-8 | Human | R & D |
| Carvedilol | C Cardiovascular System | 72956-09-3 | Human | R & D |
| Caspofungin | J Antiinfectives for Systemic Use | 162808-62-0 | Human | R & D |
| Cedazuridine | n.a. | 1141397-80-9 | Human | R & D |
| Cefaclor | J Antiinfectives for Systemic Use | 53994-73-3 | Human | R & D |
| Cefadroxil | J Antiinfectives for Systemic Use | 50370-12-2 | Human | R & D |
| Cefovecin | J Antiinfectives for Systemic Use | 234096-34-5 | Vet | R & D |
| Celecoxib | L Antineoplastic and Immunomodulating Agents M Musculo-Sekeletal System | 169590-42-5 | Human | R & D |
| Cenobamate | N Nervous System | 913088-80-9 | Human | R & D |
| Cephalexin | J Antiinfectives for Systemic Use | 15686-71-2 | Human | R & D |
| Cetilistat | n.a. | 282526-98-1 | Human | R & D |
| Chlortalidone | C Cardiovascular System | 77-36-1 | Human | R & D |
| Chlorzoxazone | M Musculo-Sekeletal System | 95-25-0 | Human | R & D |
| Cilostazol | B Blood and Blood Forming Organs | 73963-72-1 | Human | R & D |
| Cinacalcet HCl | H Systemic Hormonal Preperations, excl. Sex Hormones and Insulins | 364782-34-3 | Human | R & D |
| Citicoline Sodium | N Nervous System | 33818-15-4 | Human | R & D |
| Cladribine | L Antineoplastic and Immunomodulating Agents | 4291-63-8 | Human | R & D |
| Clascoterone | D Dermatologicals | 19608-29-8 | Human | R & D |
| Clevidipine | C Cardiovascular System | 167221-71-8 | Human | R & D |
| Clobazam | N Nervous System | 22316-47-8 | Human | R & D |
| Cobicistat | V Various | 1004316-88-4 | Human | R & D |
| Copanlisib HCl | L Antineoplastic and Immunomodulating Agents | 1402152-13-9 | Human | R & D |
| Corticotropin Acetate | H Systemic Hormonal Preperations, excl. Sex Hormones and Insulins | 12427-33-7 | Human | R & D |
| Crisaborole | D Dermatologicals | 906673-24-3 | Human | R & D |
| Crizotinib | L Antineoplastic and Immunomodulating Agents | 877399-52-5 | Human | R & D |
| Cyclobenzaprine | M Musculo-Sekeletal System | 303-53-7 | Human | R & D |
| Dabigatran | B Blood and Blood Forming Organs | 211914-51-1 | Human | R & D |
| Dabigatran Etexilate | B Blood and Blood Forming Organs | 211915-06-9 | Human | R & D |
| Dabigatran Etexilate Mesylate | B Blood and Blood forming Organs | 872728-81-9 | Human | R & D |
| Dabigatran Mesylate | B Blood and Blood forming Organs | 872728-81-9 | Human | R & D |
| Dacomitinib | L Antineoplastic and Immunomodulating Agents | 1110813-31-4 | Human | R & D |
| Dapagliflozin | A Alimentary Tract and Metabolism | 461432-26-8 | Human | R & D |
| Dapagliflozin Amorphous | A Alimentary Tract and Metabolism | 461432-26-8 | Human | R & D |
| Dapagliflozin Premix | A Alimentary Tract and Metabolism | 461432-26-8 | Human | R & D |
| Dapagliflozin Propanediol H2O | A Alimentary Tract and Metabolism | 960404-48-2 | Human | R & D |
| Dapagliflozin SPG Solvate | A Alimentary Tract and Metabolism | 461432-26-8 | Human | R & D |
| Dapoxetine HCl | G Genito Urinary System and Sex Hormones | 129938-20-1 | Human | R & D |
| Daprodustat | B Blood and Blood Forming Organs | 960539-70-2 | Human | R & D |
| Darifenacin HBr | G Genito Urinary System and Sex Hormones | 133099-07-7 | Human | R & D |
| Darolutamide | L Antineoplastic and Immunomodulating Agents | 1297538-32-9 | Human | R & D |
| Darunavir | J Antiinfectives for Systemic Use | 206361-99-1 | Human | R & D |
| Darunavir Amorphous | J Antiinfectives for Systemic Use | 206361-99-1 | Human | R & D |
| Dasatinib | L Antineoplastic and Immunomodulating Agents | 302962-49-8 | Human | R & D |
| Dasatinib H2O | L Antineoplastic and Immunomodulating Agents | 302962-49-8 | Human | R & D |
| Deflazacort | H Systemic Hormonal Preperations, excl. Sex Hormones and Insulins | 14484-47-0 | Human | R & D |
| Degarelix Acetate | L Antineoplastic and Immunomodulating Agents | 934016-19-0 | Human | R & D |
| Dehydrated Alcohol | D Dermatologicals | 64-17-5 | Human | R & D |
| Delamanid | J Antiinfectives for Systemic Use | 681492-22-8 | Human | R & D |
| Desvenlafaxine Benzoate | N Nervous System | 1147940-37-1 | Human | R & D |
| Desvenlafaxine Succinate | N Nervous System | 386750-22-7 | Human | R & D |
| Desvenlafaxine Succinate H2O | N Nervous System | 386750-22-7 | Human | R & D |
| Deucravitnib | L Antineoplastic and Immunomodulating Agents | 1609392-27-9 | Human | R & D |
| Deuterated Tetrabenazine | N Nervous System | 1392826-25-3 | Human | R & D |
| Deutetrabenazine | N Nervous System | 1392826-25-3 | Human | R & D |
| Dexlansoprazole | A Alimentary Tract and Metabolism | 138530-94-6 | Human | R & D |
| Dexmethylfendinate | N Nervous System | 40431-64-9 | Human | R & D |
| Dextromethorphan | R Respiratory System | 125-71-3 | Human | R & D |
| Dextromethorphan HBr H2O | N Nervous System | 6700-34-1 | Human | R & D |
| Diltiazem | C Cardiovascular System | 42399-41-7 | Human | R & D |
| Dimethyl Fumarate | L Antineoplastic and Immunomodulating Agents | 624-49-7 | Research | R & D |
| Diphenhydramine | D Dermatologicals R Respiratory System | 0016503-7 | Human | R & D |
| Diroximel Fumarate | L Antineoplastic and Immunomodulating Agents | 1577222-14-0 | Human | R & D |
| Dolutegravir | J Antiinfectives for Systemic Use | 1051375-16-6 | Human | R & D |
| Dolutegravir Sodium | J Antiinfectives for Systemic Use | 1051375-19-9 | Human | R & D |
| Doravirine | J Antiinfectives for Systemic Use | 1338225-97-0 | Human | R & D |
| DOTAP | n.a. | n.a. | Research | R & D |
| Doxycycline H2O | A Alimentary Tract and Metabolism J Antiinfectives for Systemic Use | 17086-28-1 | Human | R & D |
| Doxycycline Hyclate | A Alimentary Tract and Metabolism J Antiinfectives for Systemic Use | 24390-14-5 | Human | R & D |
| Doxylamine Succinate | R Respiratory System | 562-10-7 | Human | R & D |
| Drospirenone | G Genito Urinary System and Sex Hormones | 67392-87-4 | Human | R & D |
| Duloxetine | N Nervous System | 116539-59-4 | Human | R & D |
| Duvelisib | L Antineoplastic and Immunomodulating Agents | 1201438-56-3 | Human | R & D |
| Dydrogesterone | G Genito Urinary System and Sex Hormones | 152-62-5 | Human | R & D |
| Edaravone | N Nervous System | 89-25-8 | Human | R & D |
| Edoxaban | B Blood and Blood Forming Organs | 480449-70-5 | Human | R & D |
| Edoxaban Tosylate | B Blood and Blood Forming Organs | 480449-71-6 | Human | R & D |
| Efinaconazole | D Dermatologicals | 164650-44-6 | Human | R & D |
| Elagolix | H Systemic Hormonal Preperations, excl. Sex Hormones and Insulins | 832720-36-2 | Human | R & D |
| Elagolix Sodium | H Systemic Hormonal Preperations, excl. Sex Hormones and Insulins | 832720-36-2 | Human | R & D |
| Elexacaftor | R Respiratory System | 2216712-66-0 | Human | R & D |
| Eliglustat Hemitartrate | A Alimentary Tract and Metabolism | 928659-70-5 | Human | R & D |
| Eliglustat Tartrate | A Alimentary Tract and Metabolism | 928659-70-5 | Human | R & D |
| Eltrombopag | B Blood and Blood Forming Organs | 496775-61-2 | Human | R & D |
| Eltrombopag Olamine | B Blood and Blood Forming Organs | 496775-62-3 | Human | R & D |
| Eluxadoline | A Alimentary Tract and Metabolism | 864821-90-9 | Human | R & D |
| Elvitegravir | J Antiinfectives for Systemic Use | 697761-98-1 | Human | R & D |
| Elvitegravir Form III | J Antiinfectives for Systemic Use | 697761-98-1 | Human | R & D |
| Empagliflozin | A Alimentary Tract and Metabolism | 864070-44-0 | Human | R & D |
| Empagliflozin Amorphous | A Alimentary Tract and Metabolism | 864070-44-0 | Human | R & D |
| Empagliflozin Crystalline | A Alimentary Tract and Metabolism | 1210344-83-4 | Human | R & D |
| Emtricitabine | J Antiinfectives for Systemic Use | 143491-57-0 | Human | R & D |
| Enasidenib | L Antineoplastic and Immunomodulating Agents | 1446502-11-9 | Human | R & D |
| Enasidenib Mesylate | L Antineoplastic and Immunomodulating Agents | 1650550-25-6 | Human | R & D |
| Encorafenib | L Antineoplastic and Immunomodulating Agents | 1269440-17-6 | Human | R & D |
| Entrectinib | L Antineoplastic and Immunomodulating Agents | 1108743-60-7 | Human | R & D |
| Enzalutamide | L Antineoplastic and Immunomodulating Agents | 915087-33-1 | Human | R & D |
| Epacadostat | L Antineoplastic and Immunomodulating Agents | 1204669-58-8 | Human | R & D |
| Epinephrine | A Alimentary Tract and Metabolism B Blood and Blood Forming Organs C Cardiovascular System R Respiratory System S Sensory Organs | 51-43-4 | Human | R & D |
| Epinephrine Bitartrate | A Alimentary Tract and Metabolism B Blood and Blood Forming Organs C Cardiovascular System R Respiratory System S Sensory Organs | 51-42-3 | Human | R & D |
| Eplerelone | C Cardiovascular System | 107724-20-9 | Human | R & D |
| Eprosartan Mesylate | C Cardiovascular System | 144143-96-4 | Human | R & D |
| Erdafitinib | L Antineoplastic and Immunomodulating Agents | 1346242-81-6 | Human | R & D |
| Eribulin | L Antineoplastic and Immunomodulating Agents | 253128-41-5 | Human | R & D |
| Erlotinib | L Antineoplastic and Immunomodulating Agents | 183321-74-6 | Human | R & D |
| Ertugliflozin | A Alimentary Tract and Metabolism | 1210344-57-2 | Human | R & D |
| Ertugliflozin L-Pyroglutamic Acid | A Alimentary Tract and Metabolism | 1210344-57-2 | Human | R & D |
| Erythopoietin | B Blood and Blood Forming Organs | 11096-26-7 | Human | R & D |
| Erythromycin Ethyl Succinate | J Antiinfectives for Systemic Use | 1264-62-6 | Human | R & D |
| Escitalopram Oxalate | N Nervous System | 219861-08-2 | Human | R & D |
| Eslicarbazepine | N Nervous System | 104746-04-5 | Human | R & D |
| Estriol | G Genito Urinary System and Sex Hormones | 50-27-1 | Human | R & D |
| Ethambutol | J Antiinfectives for Systemic Use | 74-55-5 | Human | R & D |
| Ethinyl Estradiol | G Genito Urinary System and Sex Hormones | 57-63-6 | Human | R & D |
| Etravirine | J Antiinfectives for Systemic Use | 269055-15-4 | Human | R & D |
| Etravirine Form I | J Antiinfectives for Systemic Use | 269055-15-4 | Human | R & D |
| Evobrutinib | L Antineoplastic and Immunomodulating Agents | 1415823-73-2 | Human | R & D |
| Ezetimibe | C Cardiovascular System | 163222-33-1 | Human | R & D |
| Febuxostat | M Musculo-Sekeletal System | 144060-53-7 | Human | R & D |
| Febuxostat Form A | M Musculo-Sekeletal System | 144060-53-7 | Human | R & D |
| Fedratinib | L Antineoplastic and Immunomodulating Agents | 936091-26-8 | Human | R & D |
| Fenfluramine HCl | A Alimentary Tract and Metabolism N Nervous System | 404-82-0 | Human | R & D |
| Fenofibrate | C Cardiovascular System | 49562-28-9 | Human | R & D |
| Fenretinide | n.a. | 65646-68-6 | Human | R & D |
| Fenticonazole | G Genito Urinary System and Sex Hormones D Dermatologicals | 72479-26-6 | Human | R & D |
| Fenticonazole Nitrate | G Genito Urinary System and Sex Hormones D Dermatologicals | 73151-29-8 | Human | R & D |
| Ferric Carboxymaltose | B Blood and Blood Forming Organs | 9007-72-1 | Human | R & D |
| Ferric Maltol | B Blood and Blood Forming Organs | 33725-54-1 | Human | R & D |
| Ferrous Ascorbate | B Blood and Blood Forming Organs | 24808-52-4 | Human | R & D |
| Ferumoxytol | B Blood and Blood Forming Organs | 722492-56-0 | Human | R & D |
| Fesoterodine Fumarate | G Genito Urinary System and Sex Hormones | 286930-03-8 | Human | R & D |
| Fexofenadine | R Respiratory System | 83799-24-0 | Human | R & D |
| Fezolinetant | G Genito Urinary System and Sex Hormones | 1629229-37-3 | Human | R & D |
| Filgotinib Maleate | D Dermatologicals | 1802998-75-9 | Human | R & D |
| Finerenone | C Cardiovascular System | 1050477-31-0 | Human | R & D |
| Fingolimod HCl | L Antineoplastic and Immunomodulating Agents | 162359-56-0 | Human | R & D |
| Flibanserin | G Genito Urinary System and Sex Hormones | 167933-07-5 | Human | R & D |
| Flumethrin | P Antiparasitic Products, Insecticides and Repellents | 69770-45-2 | Vet | R & D |
| Fluralaner | P Antiparasitic Products, Insecticides and Repellents | 864731-61-3 | Vet | R & D |
| Fluvoxamine Maleate | N Nervous System | 61718-82-9 | Human | R & D |
| Folic Acid | B Blood and Blood Forming Organs V Various | 59-30-3 | Human | R & D |
| Formoterol Fumarate | R Respiratory System | 43229-80-7 | Human | R & D |
| Fosaprepitant | A Alimentary Tract and Metabolism | 172673-20-0 | Human | R & D |
| Fostamatinib | B Blood and Blood forming Organs | 901119-35-5 | Human | R & D |
| Fostamatinib Disodium | B Blood and Blood Forming Organs | 1025687-58-4 | Human | R & D |
| Fostemsavir | J Antiinfectives for Systemic Use | 864953-29-7 | Human | R & D |
| Gabapentin | N Nervous System | 60142-96-3 | Human | R & D |
| Gamithromycin | J Antiinfectives for Systemic Use | 145435-72-9 | Vet | R & D |
| Ganaxolone | N Nervous System | 38398-32-2 | Human | R & D |
| Gefapixant | R Respiratory System | 1015787-98-0 | Human | R & D |
| Gilteritinib | L Antineoplastic and Immunomodulating Agents | 1254053-43-4 | Human | R & D |
| Giredestrant | n.a. | 1953133-47-5 | Human | R & D |
| Glacial Acetic Acid | G Genito Urinary System and Sex Hormones | 64-19-7 | Research | R & D |
| Glasdegib | L Antineoplastic and Immunomodulating Agents | 1095173-27-5 | Human | R & D |
| Glatiramer Acetate | L Antineoplastic and Immunomodulating Agents | 386750-22-7 | Human | R & D |
| Glipizide | A Alimentary Tract and Metabolism | 29094-61-9 | Human | R & D |
| Glucagon Acetate | H Systemic Hormonal Preperations, excl. Sex Hormones and Insulins | 16941-32-5 | Human | R & D |
| Glycopyrrolate | A Alimentary Tract and Metabolism D Dermatologicals R Respiratory System | 596-51-0 | Human | R & D |
| Glycopyrrolate Tosylate | A Alimentary Tract and Metabolism D Dermatologicals R Respiratory System | 1624259-25-1 | Human | R & D |
| Grapiprant | M Musculo-Sekeletal System | 415903-37-6 | Vet | R & D |
| Guadecitabine | n.a. | 929901-49-5 | Human | R & D |
| Guaifenesin | R Respiratory System | 93-14-1 | Human | R & D |
| Guanfacine HCl | C Cardiovascular System | 29110-48-3 | Human | R & D |
| Hydralazine | C Cardiovascular System | 19774-82-4 | Human | R & D |
| Hydrochlorothiazide | C Cardiovascular System | 58-93-5 | Human | R & D |
| Hydroxychloroquine Sulphate | N Nervous System | 747-36-4 | Human | R & D |
| Hydroxyzine HCl | N Nervous System | 2192-20-3 | Human | R & D |
| Hydroxyzine Pamoate | N Nervous System | 10246-75-0 | Human | R & D |
| Ibrexafungerp | J Antiinfectives for Systemic Use | 1207753-03-4 | Human | R & D |
| Ibrutinib | L Antineoplastic and Immunomodulating Agents | 936563-96-1 | Human | R & D |
| Idelalisib | L Antineoplastic and Immunomodulating Agents | 870281-82-6 | Human | R & D |
| Imatinib Mesylate | L Antineoplastic and Immunomodulating Agents | 220127-57-1 | Human | R & D |
| Imeglimin | A Alimentary Tract and Metabolism C Cardiovascular System | 58-93-5 | Human | R & D |
| Indacaterol Acetate | R Respiratory System | 1000160-96-2 | Human | R & D |
| Indacaterol Maleate | R Respiratory System | 753498-25-8 | Human | R & D |
| Indocyanine Green | V Various | 3599-32-4 | Human | R & D |
| Infigratinib Phosphate | L Antineoplastic and Immunomodulating Agents | 1310746-10-1 | Human | R & D |
| Ipragliflozin | A Alimentary Tract and Metabolism | 761423-87-4 | Human | R & D |
| Irbesartan | C Cardiovascular System | 138402-11-6 | Human | R & D |
| Irinotecan | L Antineoplastic and Immunomodulating Agents | 97682-44-5 | Human | R & D |
| Isavuconazol | J Antiinfectives for Systemic Use | 241479-67-4 | Human | R & D |
| Isavuconazonium Sulphate | J Antiinfectives for Systemic Use | 946075-13-4 | Human | R & D |
| Isavuconozonium | J Antiinfectives for Systemic Use | 742049-41-8 | Human | R & D |
| Islatravir | n.a. | 865363-93-5 | Human | R & D |
| Isosulfan Blue | n.a. | 68238-36-8 | Human | R & D |
| Ivabradine HCl | C Cardiovascular System | 148849-67-6 | Human | R & D |
| Ivacaftor | R Respiratory System | 873054-44-5 | Human | R & D |
| Ivosidenib | L Antineoplastic and Immunomodulating Agents | 1448347-49-6 | Human | R & D |
| Ixazomib | L Antineoplastic and Immunomodulating Agents | 1072833-77-2 | Human | R & D |
| Ixazomib Citrate | L Antineoplastic and Immunomodulating Agents | 1239908-20-3 | Human | R & D |
| Ketamine | N Nervous System | 6740-88-1 | Human | R & D |
| Ketorolac Tromethamine | S Sensory Organs | 74103-06-3 | Human | R & D |
| Labetalol | C Cardiovascular System | 36894-69-6 | Human | R & D |
| Labetalol HCl | C Cardiovascular System | 32780-64-6 | Human | R & D |
| Lacosamide | N Nervous System | 175481-36-4 | Human | R & D |
| Lactulose | A Alimentary Tract and Metabolism | 4618-18-2 | Human | R & D |
| Laninamivir Octanoate | J Antiinfectives for Systemic Use | 203120-46-1 | Human | R & D |
| Lanreotide Acetate | H Systemic Hormonal Preperations, excl. Sex Hormones and Insulins | 127984-74 | Human | R & D |
| Larotrectinib | L Antineoplastic and Immunomodulating Agents | 1223403-58-4 | Human | R & D |
| Larotrectinib Sulphate | L Antineoplastic and Immunomodulating Agents | 1223403-58-4 | Human | R & D |
| Lasmiditan | N Nervous System | 439239-90-4 | Human | R & D |
| Lasmiditan Hemisuccinate | N Nervous System | 439239-92-6 | Human | R & D |
| Lasmiditan Succinate | N Nervous System | 439239-92-6 | Human | R & D |
| Ledipasvir | J Antiinfectives for Systemic Use | 1256388-51-8 | Human | R & D |
| Lemborexant | N Nervous System | 1369764-02-2 | Human | R & D |
| Lenalidomide | L Antineoplastic and Immunomodulating Agents | 191732-72-6 | Human | R & D |
| Lenalidomide Form B | L Antineoplastic and Immunomodulating Agents | 191732-72-6 | Human | R & D |
| Lenvatinib | L Antineoplastic and Immunomodulating Agents | 417716-92-8 | Human | R & D |
| Lenvatinib Mesylate | L Antineoplastic and Immunomodulating Agents | 857890-39-2 | Human | R & D |
| Lenvatinib Mesylate Form C | L Antineoplastic and Immunomodulating Agents | 857890-39-2 | Human | R & D |
| Lenvatinib Mesylate Form M | L Antineoplastic and Immunomodulating Agents | 857890-39-2 | Human | R & D |
| Lesinurad | M Musculo-Sekeletal System | 878672-00-5 | Human | R & D |
| Lesinurad Sodium | M Musculo-Sekeletal System | 1151516-14-1 | Human | R & D |
| Letermovir | J Antiinfectives for Systemic Use | 917389-32-3 | Human | R & D |
| Levetiracetam | N Nervous System | 102767-28-2 | Human | R & D |
| Levobupivacaine HCl | N Nervous System | 27262-48-2 | Human | R & D |
| Levomilnacipran HCl | N Nervous System | 175131-60-9 | Human | R & D |
| Levosimendan | C Cardiovascular System | 141505-33-1 | Human | R & D |
| Levothyroxine | H Systemic Hormonal Preperations, excl. Sex Hormones and Insulins | 51-48-9 | Human | R & D |
| Lifitegrast | S Sensory Organs | 1025967-78-5 | Human | R & D |
| Linaclotide | A Alimentary Tract and Metabolism | 851199-59-2 | Human | R & D |
| Linaclotide Acetate | A Alimentary Tract and Metabolism | 851199-60-5 | Human | R & D |
| Linagliptin | A Alimentary Tract and Metabolism | 668270-12-0 | Human | R & D |
| Linagliptin Form C | A Alimentary Tract and Metabolism | 846589-98-8 | Human | R & D |
| Linzagolix | H Systemic Hormonal Preperations, excl. Sex Hormones and Insulins | 935283-04-8 | Human | R & D |
| Liraglutide | A Alimentary Tract and Metabolism | 204656-20-2 | Human | R & D |
| Liraglutide Acetate | A Alimentary Tract and Metabolism | 204656-20-2 | Human | R & D |
| Lisinopril | C Cardiovascular System | 76547-98-3 | Human | R & D |
| lndacoterol Acetate | R Respiratory System | 1000160-96-2 | Human | R & D |
| Lofexidine | N Nervous System | 31036-80-3 | Human | R & D |
| Lopinavir | J Antiinfectives for Systemic Use | 192725-17-0 | Human | R & D |
| Lorcaserin HCI | A Alimentary Tract and Metabolism | 846589-98-8 | Human | R & D |
| Lorlatinib | L Antineoplastic and Immunomodulating Agents | 1454846-35-5 | Human | R & D |
| Losartan | C Cardiovascular System | 114798-26-4 | Human | R & D |
| Losartan Potassium | C Cardiovascular System | 124750-99-8 | Human | R & D |
| Luliconazole | D Dermatologicals | 187164-19-8 | Human | R & D |
| Lumacaftor | R Respiratory System | 936727-05-8 | Human | R & D |
| Lumateperone Tosylate | N Nervous System | 313368-91-1 | Human | R & D |
| Lurasidone | N Nervous System | 367514-87-2 | Human | R & D |
| Lurasidone HCl | N Nervous System | 367514-88-3 | Human | R & D |
| Lurbinectedin | L Antineoplastic and Immunomodulating Agents | 497871-47-3 | Human | R & D |
| Lusutrombopag | B Blood and Blood Forming Organs | 1110766-97-6 | Human | R & D |
| Macitentan | C Cardiovascular System | 441798-33-0 | Human | R & D |
| Maraviroc | J Antiinfectives for Systemic Use | 376348-65-1 | Human | R & D |
| Maraviroc Potassium | J Antiinfectives for Systemic Use | 376348-65-1 | Human | R & D |
| Maraviroc Potassium Amorphous | J Antiinfectives for Systemic Use | 376348-65-1 | Human | R & D |
| Maraviroc Potassium Form B | J Antiinfectives for Systemic Use | 376348-65-1 | Human | R & D |
| Marbofloxacin | J Antiinfectives for Systemic Use | 115550-35-1 | Vet | R & D |
| Mavacamten | C Cardiovascular System | 1642288-47-8 | Human | R & D |
| Meclizine HCl | R Respiratory System | 1104-22-9 | Human | R & D |
| Melengestrol Acetate | n.a. | 2919-66-6 | Vet | R & D |
| Memantine | N Nervous System | 19982-08-2 | Human | R & D |
| Mesalamine | A Alimentary Tract and Metabolism | 89-57-6 | Human | R & D |
| Mesalazine | A Alimentary Tract and Metabolism | 89-57-6 | Human | R & D |
| Methocarbamol | M Musculo-Sekeletal System | 532-03-6 | Human | R & D |
| Methotrexate | L Antineoplastic and Immunomodulating Agents | 59-05-2 | Human | R & D |
| Methylene Blue | V Various | 61-73-4 | Human | R & D |
| Metoprolol Succinate | C Cardiovascular System | 98418-47-4 | Human | R & D |
| Metyrosine | C Cardiovascular System | 672-87-7 | Human | R & D |
| Micafungin | J Antiinfectives for Systemic Use | 235114-32-6 | Human | R & D |
| Midostaurin | L Antineoplastic and Immunomodulating Agents | 120685-11-2 | Human | R & D |
| Migalastat HCl | A Alimentary Tract and Metabolism | 75172-81-5 | Human | R & D |
| Miglustat | A Alimentary Tract and Metabolism | 72599-27-0 | Human | R & D |
| Milnacipran HCl | N Nervous System | 101152-94-7 | Human | R & D |
| Milrinone Lactate | C Cardiovascular System | 100286-97-3 | Human | R & D |
| Mirabegron | G Genito Urinary System and Sex Hormones | 223673-61-8 | Human | R & D |
| Mirabegron Alpha Form | G Genito Urinary System and Sex Hormones | 223673-61-8 | Human | R & D |
| Mirogabalin | N Nervous System | 1138245-13-2 | Human | R & D |
| Mirogabalin Besylate | N Nervous System | 1138245-13-2 | Human | R & D |
| Mitavipat | B Blood and Blood Forming Organs | 1260075-17-9 | Human | R & D |
| Molnupiravir | J Antiinfectives for Systemic Use | 2492423-29-5 | Human | R & D |
| Montelukast Sodium | R Respiratory System | 151767-02-1 | Human | R & D |
| Mycophenolate Sodium | L Antineoplastic and Immunomodulating Agents | 37415-62-6 | Human | R & D |
| Nafamostat Mesylate | n.a. | 82956-11-4 | Human | R & D |
| Naftifine | D Dermatologicals | 65472-88-0 | Human | R & D |
| Naloxegol Oxalate | A Alimentary Tract and Metabolism | 1354744-91-4 | Human | R & D |
| Naproxen Sodium | G Genito Urinary System and Sex Hormones | 26159-34-2 | Human | R & D |
| Nebivolol | C Cardiovascular System | 118457-14-0 | Human | R & D |
| Nebivolol HCl | C Cardiovascular System | 152520-56-4 | Human | R & D |
| Nefazodone | N Nervous System | 83366-66-9 | Human | R & D |
| Nelarabine | L Antineoplastic and Immunomodulating Agents | 121032-29-9 | Human | R & D |
| Neratinib | L Antineoplastic and Immunomodulating Agents | 698387-09-6 | Human | R & D |
| Netarsudil Dimesylate | S Sensory Organs | 1422144-42-0 | Human | R & D |
| Nicardipine HCl | C Cardiovascular System | 54527-84-3 | Human | R & D |
| Nicorandil | C Cardiovascular System | 65141-46-0 | Human | R & D |
| Nifedipine | C Cardiovascular System | 21829-25-4 | Human | R & D |
| Nilotinib | L Antineoplastic and Immunomodulating Agents | 641571-10-0 | Human | R & D |
| Nilotinib Fumarate | L Antineoplastic and Immunomodulating Agents | 1304125-88-9 | Human | R & D |
| Nilotinib HCl | L Antineoplastic and Immunomodulating Agents | 923288-95-3 | Human | R & D |
| Nilotinib Tartrate | L Antineoplastic and Immunomodulating Agents | 1353151-37-7 | Human | R & D |
| Nintedanib | L Antineoplastic and Immunomodulating Agents | 656247-17-5 | Human | R & D |
| Nintedanib Esylate | L Antineoplastic and Immunomodulating Agents | 656247-18-6 | Human | R & D |
| Nintedanib Esylate 0.5H2O | L Antineoplastic and Immunomodulating Agents | 656247-18-6 | Human | R & D |
| Niraparib Tosylate | L Antineoplastic and Immunomodulating Agents | 1038915-73-9 | Human | R & D |
| Nirmatrelvir | n.a. | 2628280-40-8 | Human | R & D |
| Nitrofurantoin Macrocrystal | J Antiinfectives for Systemic Use | 67-20-10 | Human | R & D |
| Noradrenaline Bitartrate | C Cardiovascular System | 51-40-1 | Human | R & D |
| Norepinephrine Bitartrate | C Cardiovascular System | 69815-49-2 | Human | R & D |
| Obeticholic Acid | A Alimentary Tract and Metabolism | 459789-99-2 | Human | R & D |
| Octenidine | R Respiratory System | 70775-75-6 | Human | R & D |
| Olaparib | L Antineoplastic and Immunomodulating Agents | 763113-22-0 | Human | R & D |
| Olaparib Form A | L Antineoplastic and Immunomodulating Agents | 763113-22-0 | Human | R & D |
| Olaparib Form H | L Antineoplastic and Immunomodulating Agents | 763113-22-0 | Human | R & D |
| Olmesartan | C Cardiovascular System | 144689-24-7 | Human | R & D |
| Olmesartan Medoximil | c Cardiovascular System | 144689-63-4 | Human | R & D |
| Olodaterol | R Respiratory System | 868049-49-4 | Human | R & D |
| Olodaterol HCl | R Respiratory System | 869477-96-3 | Human | R & D |
| Omadacycline | J Antiinfectives for Systemic Use | 389139-89-3 | Human | R & D |
| Opicapone | N Nervous System | 923287-50-7 | Human | R & D |
| Osimertinib | L Antineoplastic and Immunomodulating Agents | 1421373-65-0 | Human | R & D |
| Osimertinib Mesylate | L Antineoplastic and Immunomodulating Agents | 1421373-66-1 | Human | R & D |
| Ospemifene | G Genito Urinary System and Sex Hormones | 128607-22-7 | Human | R & D |
| Oteseconazole | J Antiinfectives for Systemic Use | 1340593-59-0 | Human | R & D |
| Oxcarbazepine | N Nervous System | 28721-07-5 | Human | R & D |
| Ozanimod HCl | L Antineoplastic and Immunomodulating Agents | 1618636-37-5 | Human | R & D |
| Ozenoxacin | D Dermatologicals | 245765-41-7 | Human | R & D |
| Palbociclib | L Antineoplastic and Immunomodulating Agents | 571190-30-2 | Human | R & D |
| Paliperidone | N Nervous System | 144598-75-4 | Human | R & D |
| Pancrelipase | A Alimentary Tract and Metabolism | 53608-75-6 | Human | R & D |
| Pantoprazole Sodium | A Alimentary Tract and Metabolism | 138786-67-1 | Human | R & D |
| Patiromer Calcium Sorbitex | V Various | 1260645-52-4 | Human | R & D |
| Pazopanib | L Antineoplastic and Immunomodulating Agents | 444731-52-6 | Human | R & D |
| Pazopanib HCl | L Antineoplastic and Immunomodulating Agents | 635702-64-6 | Human | R & D |
| Peficitinib | L Antineoplastic and Immunomodulating Agents | 944118-01-8 | Human | R & D |
| Pemetrexed | L Antineoplastic and Immunomodulating Agents | 137281-23-3 | Human | R & D |
| Pemigatinib | L Antineoplastic and Immunomodulating Agents | 1513857-77-6 | Human | R & D |
| Perampanel | N Nervous System | 380917-97-5 | Human | R & D |
| Pergolide | N Nervous System | 66104-22-1 | Vet | R & D |
| Permethrine | P Antiparasitic Products, Insecticides and Repellents | 52645-53-1 | Human | R & D |
| Phenylephrine | C Cardiovascular System R Respiratory System S Sensory Organs | 59-42-7 | Human | R & D |
| Pimavanserin | N Nervous System | 706779-91-1 | Human | R & D |
| Pimavanserin Hemitartrate | N Nervous System | 706782-28-7 | Human | R & D |
| Pimavanserin Tartrate | N Nervous System | 706782-28-7 | Human | R & D |
| Pinaverium Br | A Alimentary Tract and Metabolism | 53251-94-8 | Human | R & D |
| Pioglitazone | A Alimentary Tract and Metabolism | 111025-46-8 | Human | R & D |
| Pirfenidone | L Antineoplastic and Immunomodulating Agents | 53179-13-8 | Human | R & D |
| Pitavastatin Calcium | C Cardiovascular System | 147526-32-7 | Human | R & D |
| Pitolisant | N Nervous System | 362665-56-3 | Human | R & D |
| Pitolisant HCl | N Nervous System | 903576-44-3 | Human | R & D |
| Plerixafor | L Antineoplastic and Immunomodulating Agents | 110078-46-1 | Human | R & D |
| Plinabulin | n.a. | 714272-27-2 | Human | R & D |
| Pomalidomide | L Antineoplastic and Immunomodulating Agents | 19171-19-8 | Human | R & D |
| Pomalidomide Form A | L Antineoplastic and Immunomodulating Agents | 19171-19-8 | Human | R & D |
| Ponatinib | L Antineoplastic and Immunomodulating Agents | 943319-70-8 | Human | R & D |
| Ponatinib HCl | L Antineoplastic and Immunomodulating Agents | 1114544-31-8 | Human | R & D |
| Posaconazole | A Alimentary Tract and Metabolism J Antiinfectives for Systemic Use | 171228-49-2 | Human | R & D |
| Posaconazole Form I | A Alimentary Tract and Metabolism J Antiinfectives for Systemic Use | n.a. | Human | R & D |
| Pralsetinib | L Antineoplastic and Immunomodulating Agents | 2097132-94-8 | Human | R & D |
| Pramipexole 2HCl H2O | n.a. | 191217-81-9 | Human | R & D |
| Prednisolone Acetate | S Sensory Organs | 52-21-1 | Human | R & D |
| Pretomanid | J Antiinfectives for Systemic Use | 187235-37-6 | Human | R & D |
| Primidone | N Nervous System | 125-33-7 | Human | R & D |
| Propanolol | C Cardiovascular System | 525-66-6 | Human | R & D |
| Propofol | N Nervous System | 2078-54-8 | Human | R & D |
| Prucalopride Succinate | A Alimentary Tract and Metabolism | 179474-85-2 | Human | R & D |
| Pyrazinamide | J Antiinfectives for Systemic Use | 98-96-4 | Human | R & D |
| Pyridostigmine Br | N Nervous System | 101-26-8 | Human | R & D |
| Pyrotinib Maleate | L Antineoplastic and Immunomodulating Agents | 1397922-61-0 | Human | R & D |
| Quetiapine Fumarate | N Nervous System | 111974-72-2 | Human | R & D |
| Ralinepag | n.a. | 1187856-49-0 | Human | R & D |
| Raloxifene | G Genito Urinary System and Sex Hormones | 84449-90-1 | Human | R & D |
| Raloxifene HCl | G Genito Urinary System and Sex Hormones | 82640-04-8 | Human | R & D |
| Raltegravir | J Antiinfectives for Systemic Use | 518048-05-0 | Human | R & D |
| Raltegravir Form I | J Antiinfectives for Systemic Use | 871038-72-1 | Human | R & D |
| Raltegravir Form III | J Antiinfectives for Systemic Use | 518048-05-0 | Human | R & D |
| Raltegravir Potassium | J Antiinfectives for Systemic Use | 871038-72-1 | Human | R & D |
| Raltegravir Potassium Form III | J Antiinfectives for Systemic Use | 871038-72-1 | Human | R & D |
| Ranolazine | C Cardiovascular System | 95635-55-5 | Human | R & D |
| Regadenoson | C Cardiovascular System | 313348-27-5 | Human | R & D |
| Regadenoson Anhydrous | C Cardiovascular System | 313348-27-5 | Human | R & D |
| Regadenoson H2O | C Cardiovascular System | 875148-45-1 | Human | R & D |
| Regorafenib | L Antineoplastic and Immunomodulating Agents | 755037-03-7 | Human | R & D |
| Relebactam | J Antiinfectives for Systemic Use | 1174018-99-5 | Human | R & D |
| Relugolix | L Antineoplastic and Immunomodulating Agents | 737789-87-6 | Human | R & D |
| Remdesivir | J Antiinfectives for Systemic Use | 1809249-37-3 | Human | R & D |
| Remimazolam | N Nervous System | 308242-62-8 | Human | R & D |
| Revefenacln | R Respiratory System | 864750-70-9 | Human | R & D |
| Ribociclib Succinate | L Antineoplastic and Immunomodulating Agents | 1374639-75-4 | Human | R & D |
| Rifabutin | J Antiinfectives for Systemic Use | 72559-06-9 | Human | R & D |
| Rifaximin | A Alimentary Tract and Metabolism D Dermatologicals | 80621-81-4 | Human | R & D |
| Rilpivirine | J Antiinfectives for Systemic Use | 500287-72-9 | Human | R & D |
| Rilpivirine HCl | J Antiinfectives for Systemic Use | 700361-47-3 | Human | R & D |
| Rimegepant | N Nervous System | 1289023-67-1 | Human | R & D |
| Rimegepant Sulphate | N Nervous System | 1374024-48-2 | Human | R & D |
| Riociguat | C Cardiovascular System | 625115-55-1 | Human | R & D |
| Riociguat Modification-I | C Cardiovascular System | 625115-55-1 | Human | R & D |
| Ripasudil | S Sensory Organs | 223645-67-8 | Human | R & D |
| Ripretinib | L Antineoplastic and Immunomodulating Agents | 1442472-39-0 | Human | R & D |
| Risdiplam | M Musculo-Sekeletal System | 1825352-65-5 | Human | R & D |
| Ritlecitinib | n.a. | 1792180-81-4 | Human | R & D |
| Ritonavir | J Antiinfectives for Systemic Use | 155213-67-5 | Human | R & D |
| Ritonavir Hot Melt Extrudate | J Antiinfectives for Systemic Use | n.a. | Human | R & D |
| Rivaroxaban | B Blood and Blood Forming Organs | 366789-02-8 | Human | R & D |
| Rocuronium Br | M Musculo-Sekeletal System | 119302-91-9 | Human | R & D |
| Roflumilast | R Respiratory System | 162401-32-3 | Human | R & D |
| Ropivacaine HCl | N Nervous System | 132112-35-7 | Human | R & D |
| Rosuvastatin | C Cardiovascular System | 287714-41-4 | Human | R & D |
| Rotigotine | N Nervous System | 99755-59-6 | Human | R & D |
| Rotigotine Form II | N Nervous System | 99755-59-6 | Human | R & D |
| Roxadustat | B Blood and Blood Forming Organs | 808118-40-3 | Human | R & D |
| Rucaparib Camsylate | L Antineoplastic and Immunomodulating Agents | 1859053-21-6 | Human | R & D |
| Rufinamide | N Nervous System | 106308-44-5 | Human | R & D |
| Rupatadine Fumarate | R Respiratory System | 182349-12-8 | Human | R & D |
| Ruxolitinib | L Antineoplastic and Immunomodulating Agents | 941678-49-5 | Human | R & D |
| Ruxolitinib Phosphate | L Antineoplastic and Immunomodulating Agents | 1092939-17-7 | Human | R & D |
| Sacubitril | C Cardiovascular System | 149709-62-6 | Human | R & D |
| Sacubitril Sodium | C Cardiovascular System | 149690-05-1 | Human | R & D |
| Sacubitril Valsartan | C Cardiovascular System | 936623-90-4 | Human | R & D |
| Sacubitril Valsartan Complex | C Cardiovascular System | 936623-90-4 | Human | R & D |
| Sacubitril Valsartan Trisodium Hemipentahydrate | C Cardiovascular System | 149709-62-6 | Human | R & D |
| Safinamide | N Nervous System | 133865-89-1 | Human | R & D |
| Safinamide Methanesulfonate | N Nervous System | 202825-46-5 | Human | R & D |
| Samidorphan | N Nervous System | 852626-89-2 | Human | R & D |
| Sapropterin | A Alimentary Tract and Metabolism | 62989-33-7 | Human | R & D |
| Saxagliptin | A Alimentary Tract and Metabolism | 361442-04-8 | Human | R & D |
| Saxagliptin H2O | A Alimentary Tract and Metabolism | 945667-22-1 | Human | R & D |
| Saxagliptin HCl | A Alimentary Tract and Metabolism | 709031-78-7 | Human | R & D |
| Saxagliptin HCl 2H2O | A Alimentary Tract and Metabolism | 1073057-20-1 | Human | R & D |
| Scopolamine Butylbromide | A Alimentary Tract and Metabolism | 149-64-4 | Human | R & D |
| Selenous Acid | D Dermatologicals | 7783-00-8 | Research | R & D |
| Selexipag | B Blood and Blood Forming Organs | 475086-01-2 | Human | R & D |
| Selexipag Form I | B Blood and Blood Forming Organs | 475086-01-2 | Human | R & D |
| Selinexor | L Antineoplastic and Immunomodulating Agents | 1393477-72-9 | Human | R & D |
| Selpercatinib | L Antineoplastic and Immunomodulating Agents | 2152628-33-4 | Human | R & D |
| Selumetinib | L Antineoplastic and Immunomodulating Agents | 606143-52-6 | Human | R & D |
| Selumetinib Sulphate | L Antineoplastic and Immunomodulating Agents | 943332-08-9 | Human | R & D |
| Semaglutide | A Alimentary Tract and Metabolism | 910463-68-2 | Human | R & D |
| Semaglutide Acetate | A Alimentary Tract and Metabolism | 910463-68-2 | Human | R & D |
| Sertraline HCl Form I | N Nervous System | 79559-97-0 | Human | R & D |
| Setmelanotide Acetate | A Alimentary Tract and Metabolism | 920014-72-8 | Human | R & D |
| Sildenafil Citrate | G Genito Urinary System and Sex Hormones | 171599-83-0 | Human | R & D |
| Silodosin | G Genito Urinary System and Sex Hormones | 160970-54-7 | Human | R & D |
| Simvastatin | C Cardiovascular System | 79902-63-9 | Human | R & D |
| Siponimod | L Antineoplastic and Immunomodulating Agents | 1230487-00-9 | Human | R & D |
| Siponimod Fumarate | L Antineoplastic and Immunomodulating Agents | 1234627-85-0 | Human | R & D |
| Sirolimus | S Sensory Organs L Antineoplastic and Immunomodulating Agents | 53123-88-9 | Human | R & D |
| Sitagliptin | A Alimentary Tract and Metabolism | 486460-32-6 | Human | R & D |
| Sitagliptin HCl | A Alimentary Tract and Metabolism | 486459-71-6 | Human | R & D |
| Sitagliptin Phosphate | A Alimentary Tract and Metabolism | 654671-77-9 | Human | R & D |
| Sitagliptin Phosphate Anhydrous | A Alimentary Tract and Metabolism | 654671-78-0 | Human | R & D |
| Sitagliptin Phosphate H2O | A Alimentary Tract and Metabolism | 654671-77-9 | Human | R & D |
| Sodium Cromolyn / Cromoglycate | n.a. | n.a. | Human | R & D |
| Sofosbuvir | J Antiinfectives for Systemic Use | 1190307-88-0 | Human | R & D |
| Sofpironium Br | n.a. | 1628106-94-4 | Human | R & D |
| Solithromycin | J Antiinfectives for Systemic Use | 760981-83-7 | Human | R & D |
| Solriamfetol HCl | N Nervous System | 178429-65-7 | Human | R & D |
| Sotagliflozin | A Alimentary Tract and Metabolism | 1018899-04-1 | Human | R & D |
| Sotorasib | L Antineoplastic and Immunomodulating Agents | 2296729-00-3 | Human | R & D |
| Sparsentan | n.a. | 254740-64-2 | Human | R & D |
| Spironolactone | C Cardiovascular System | 52-01-7 | Human | R & D |
| Staurosporine | n.a. | 62996-74-1 | Research | R & D |
| Succinylcholine Choride | n.a. | 71-27-2 | Human | R & D |
| Sucroferric Oxyhydroxide | V Various | 20344-49-4 | Human | R & D |
| Sugammadex | V Various | 343306-71-8 | Human | R & D |
| Sugammadex Sodium | V Various | 343306-79-6 | Human | R & D |
| Sulfoxide | M Musculo-Sekeletal System | 120-62-7 | Research | R & D |
| Sunitinib Malate | M Musculo-Sekeletal System | 341031-54-7 | Human | R & D |
| Suvorexant | N Nervous System | 1030377-33-3 | Human | R & D |
| Tadalafil | G Genito Urinary System and Sex Hormones | 171596-29-5 | Human | R & D |
| Tafamidis | N Nervous System | 594839-88-0 | Human | R & D |
| Tafamidis Meglumine | N Nervous System | 951395-08-7 | Human | R & D |
| Talazoparib Tosylate | L Antineoplastic and Immunomodulating Agents | 1373431-65-2 | Human | R & D |
| Tamoxifen Citrate | L Antineoplastic and Immunomodulating Agents | 54965-24-1 | Human | R & D |
| Tamsulosin HCl | G Genito Urinary System and Sex Hormones | 106463-17-6 | Human | R & D |
| Tapentadol HCl | N Nervous System | 175591-09-0 | Human | R & D |
| Tavaborole | D Dermatologicals | 174671-46-6 | Human | R & D |
| Tazemetostat HBr | L Antineoplastic and Immunomodulating Agents | 1467052-75-0 | Human | R & D |
| Teduglutide | A Alimentary Tract and Metabolism | 197922-42-2 | Human | R & D |
| Teduglutide Acetate | A Alimentary Tract and Metabolism | 197922-42-2 | Human | R & D |
| Tegaserod | A Alimentary Tract and Metabolism | 145158-71-0 | Human | R & D |
| Tegaserod Maleate | A Alimentary Tract and Metabolism | 189188-57-6 | Human | R & D |
| Telmisartan | C Cardiovascular System | 144701-48-4 | Human | R & D |
| Telotristat | A Alimentary Tract and Metabolism | 1033805-22-9 | Human | R & D |
| Telotristat Etiprate | A Alimentary Tract and Metabolism | 1137608-69-5 | Human | R & D |
| Tenapanor | A Alimentary Tract and Metabolism | 1234365-97-9 | Human | R & D |
| Tenapanor HCl | A Alimentary Tract and Metabolism | 1234365-97-9 | Human | R & D |
| Teneligliptin HBr H2O | A Alimentary Tract and Metabolism | 1572583-29-9 | Human | R & D |
| Tenofovir | J Antiinfectives for Systemic Use | 147127-20-6 | Human | R & D |
| Tenofovir Alafenamide Fumarate | J Antiinfectives for Systemic Use | 1392275-56-7 | Human | R & D |
| Tenofovir Alafenamide Hemifumarate | J Antiinfectives for Systemic Use | 1392275-56-7 | Human | R & D |
| Tenofovir Alafenamide Maleate | J Antiinfectives for Systemic Use | 379270-38-9 | Human | R & D |
| Tenofovir Disoproxil Fumarate | J Antiinfectives for Systemic Use | 202138-50-9 | Human | R & D |
| Tepotinib | L Antineoplastic and Immunomodulating Agents | 1100598-32-0 | Human | R & D |
| Teriflunomide | L Antineoplastic and Immunomodulating Agents | 108605-62-5 | Human | R & D |
| Tesetaxel | n.a. | 333754-36-2 | Human | R & D |
| Tezacaftor | R Respiratory System | 1152311-62-0 | Human | R & D |
| Thiocolchicoside | M Musculo-Sekeletal System | 602-41-5 | Human | R & D |
| Thiothixene | N Nervous System | 3313-26-6 | Human | R & D |
| Tiagabine HCl | N Nervous System | 115103-54-3 | Human | R & D |
| Ticagrelor | B Blood and Blood Forming Organs | 274693-27-5 | Human | R & D |
| Ticagrelor Form II | B Blood and Blood forming Organs | 274693-27-5 | Human | R & D |
| Tigecycline HCl | J Antiinfectives for Systemic Use | 197654-04-9 | Human | R & D |
| Tildipirosin | J Antiinfectives for Systemic Use | 328898-40-4 | Vet | R & D |
| Tiotropium Br | R Respiratory System | 136310-93-5 | Human | R & D |
| Tipiracil | L Antineoplastic and Immunomodulating Agents | 183204-74-2 | Human | R & D |
| Tirbanibulin | D Dermatologicals | 897016-82-9 | Human | R & D |
| Tivozanib | L Antineoplastic and Immunomodulating Agents | 475108-18-0 | Human | R & D |
| Tivozanib HCl H2O | L Antineoplastic and Immunomodulating Agents | 682745-41-1 | Human | R & D |
| Toceranib | L Antineoplastic and Immunomodulating Agents | 356068-94-5 | Vet | R & D |
| Tofacitinib | L Antineoplastic and Immunomodulating Agents | 477600-75-2 | Human | R & D |
| Tofacitinib Citrate | L Antineoplastic and Immunomodulating Agents | 540737-29-9 | Human | R & D |
| Tolvaptan | C Cardiovascular System | 150683-30-0 | Human | R & D |
| Topiramate | N Nervous System | 97240-79-4 | Human | R & D |
| Tramadol HCl | N Nervous System | 36282-47-0 | Human | R & D |
| Trametinib Dimethyl | L Antineoplastic and Immunomodulating Agents | 1187431-43-1 | Human | R & D |
| Trametinib Dimethyl Sulfoxide | L Antineoplastic and Immunomodulating Agents | 1187431-43-1 | Human | R & D |
| Tranexamic Acid | B Blood and Blood Forming Organs | 1197-18-8 | Human | R & D |
| Trazodone | N Nervous System | 19794-93-5 | Human | R & D |
| Trazodone HCl | N Nervous System | 25332-39-2 | Human | R & D |
| Trelagliptin | n.a. | 865759-25-7 | Human | R & D |
| Trenbolone Acetate | n.a. | 10161-33-8 | Vet | R & D |
| Trientine 2HCl | A Alimentary Tract and Metabolism | 38260-01-4 | Human | R & D |
| Trifarotene | D Dermatologicals | 895542-09-3 | Human | R & D |
| Trifluridine | S Sensory Organs | 70-00-8 | Human | R & D |
| Trilaciclib | V Various | 1374743-00-6 | Human | R & D |
| Trilaciclib 2HCl | V Various | 2519335-12-5 | Human | R & D |
| Triptorelin Acetate | L Antineoplastic and Immunomodulating Agents | 140194-24-7 | Human | R & D |
| Tucatinib | L Antineoplastic and Immunomodulating Agents | 937263-43-9 | Human | R & D |
| Ubrogepant | N Nervous System | 1374248-77-7 | Human | R & D |
| Umbralisib | L Antineoplastic and Immunomodulating Agents | 1532533-67-7 | Human | R & D |
| Umbralisib Tosylate | L Antineoplastic and Immunomodulating Agents | 1532533-72-4 | Human | R & D |
| Umeclidinium Br | R Respiratory System | 869113-09-7 | Human | R & D |
| Umifenovir HCI | J Antiinfectives for Systemic Use | 131707-23-8 | Human | R & D |
| Upadacitnib | L Antineoplastic and Immunomodulating Agents | 1310726-60-3 | Human | R & D |
| Urapidil HCl H2O | C Cardiovascular System | 64887-14-5 | Human | R & D |
| Ursodeoxycholic Acid | A Alimentary Tract and Metabolism | 128-13-2 | Human | R & D |
| Vadadustat | B Blood and Blood Forming Organs | 1000025-07-9 | Human | R & D |
| Valacyclovir | J Antiinfectives for Systemic Use | 124832-26-4 | Human | R & D |
| Valbenazine | N Nervous System | 1025504-45-3 | Human | R & D |
| Valbenazine Tosylate | N Nervous System | 1639208-54-0 | Human | R & D |
| Valsartan / Sacubitril | C Cardiovascular System | 137862-53-4 | Human | R & D |
| Varenicline | N Nervous System S Sensory Organs | 249296-44-4 | Human | R & D |
| Varenicline Tartrate | N Nervous System S Sensory Organs | 375815-87-5 | Human | R & D |
| Vecuronium HBr | M Musculo-Sekeletal System | 50700-72-6 | Human | R & D |
| Velpatasvir | J Antiinfectives for Systemic Use | 1377049-84-7 | Human | R & D |
| Vemurafenib | L Antineoplastic and Immunomodulating Agents | 1029872-54-5 | Human | R & D |
| Venetoclax | L Antineoplastic and Immunomodulating Agents | 1257044-40-8 | Human | R & D |
| Venglustat | n.a. | 1401090-53-6 | Human | R & D |
| Vericiguat | C Cardiovascular System | 1350653-20-1 | Human | R & D |
| Vibegron | G Genito Urinary System and Sex Hormones | 1190389-15-1 | Human | R & D |
| Vilanterol | R Respiratory System | 503068-34-6 | Human | R & D |
| Vilanterol Trifenatate | R Respiratory System | 503070-58-4 | Human | R & D |
| Vilazidone | N Nervous System | 163521-12-8 | Human | R & D |
| Vildaglibtin | A Alimentary Tract and Metabolism | 274901-16-5 | Human | R & D |
| Viloxazine | N Nervous System | 46817-91-8 | Human | R & D |
| Viloxazine HCl | N Nervous System | 46817-91-8 | Human | R & D |
| Vismodegib | L Antineoplastic and Immunomodulating Agents | 879085-55-9 | Human | R & D |
| Voclosporin | L Antineoplastic and Immunomodulating Agents | 515814-01-4 | Human | R & D |
| Vonoprazan | A Alimentary Tract and Metabolism | 881681-01-2 | Human | R & D |
| Vonoprazan Fumarate | A Alimentary Tract and Metabolism | 1260141-27-2 | Human | R & D |
| Vortioxetine | N Nervous System | 508233-74-7 | Human | R & D |
| Vortioxetine HBr | N Nervous System | 960203-27-4 | Human | R & D |
| Voxelotor | B Blood and Blood Forming Organs | 1446321-46-5 | Human | R & D |
| Warfarin Sodium | B Blood and Blood Forming Organs | 129-06-6 | Human | R & D |
| Zanubrutinib | L Antineoplastic and Immunomodulating Agents | 1691249-45-2 | Human | R & D |
| Zolmitriptan | N Nervous System | 139264-17-8 | Human | R & D |
| Zuranolone | N Nervous System | 1632051-40-1 | Human | R & D |
We also offer a portfolio of Intermediate, Extracts, and Excipients. Please contact us by filling out the contact form on this webpage, or directly send an email to info-api@tiefenbacher.com.
| Product name | ATC | CAS No. | Category | Commercial API / R & D |
|---|---|---|---|---|
| 5-Fluorocytosine | D Dermatologicals J Antiifectives for Systemic Use | 2022-85-7 | Human | R & D |
| Abacavir | J Antiinfectives for Systemic Use | 136470-78-5 | Human | R & D |
| Abaloparatide Acetate | H Systemic Hormonal Preperations, excl. Sex Hormones and Insulins | 247062-33-5 | Human | R & D |
| Abemaciclib | L Antineoplastic and Immunomodulating Agents | 1231929-97-7 | Human | R & D |
| Abiraterone | L Antineoplastic and Immunomodulating Agents | 154229-19-3 | Human | R & D |
| Abiraterone Acetate | L Antineoplastic and Immunomodulating Agents | 154229-18-2 | Human | R & D |
| Abrocitinib | D Dermatologicals | 1622902-68-4 | Human | R & D |
| Acalabrutinib | L Antineoplastic and Immunomodulating Agents | 1420477-60-6 | Human | R & D |
| Acamprosate | N Nervous System | 77337-76-9 | Human | R & D |
| Aclidinium Br | R Respiratory System | 320345-99-1 | Human | R & D |
| Acyclovir | J Antiinfectives for Systemic Use | 59277-89-3 | Human | R & D |
| Adrenaline Bitartrate | C Cardiovascular System | 51-42-3 | Human | R & D |
| Afatinib | L Antineoplastic and Immunomodulating Agents | 850140-72-6 | Human | R & D |
| Afatinib Dimaleate | L Antineoplastic and Immunomodulating Agents | 850140-73-7 | Human | R & D |
| Afoxolaner | P Antiparasitic Products, Insecticides and Repellents | 1093861-60-9 | Vet | R & D |
| Agomelatine | N Nervous System | 138112-76-2 | Human | R & D |
| Albendazole | P Antiparasitic Products, Insecticides and Repellents | 54965-21-8 | Human | R & D |
| Alectinib HCl | L Antineoplastic and Immunomodulating Agents | 1256589-74-8 | Human | R & D |
| Alizapride | A Alimentary Tract and Metabolism | 59338-93-1 | Human | R & D |
| Allopurinol | M Musculo-Sekeletal System | 315-30-0 | Human | R & D |
| Alogliptin | A Alimentary Tract and Metabolism | 850649-61-5 | Human | R & D |
| Alogliptin Benzoate | A Alimentary Tract and Metabolism | 850649-62-6 | Human | R & D |
| Alpelisib | L Antineoplastic and Immunomodulating Agents | 1217486-61-7 | Human | R & D |
| Amifampridin Phosphate | N Nervous System | 446254-47-3 | Human | R & D |
| Amiodarone HCl | C Cardiovascular System | 19774-82-4 | Human | R & D |
| Amlodipin Besylate | C Cardiovascular System | 111470-99-6 | Human | R & D |
| Amlodipine | C Cardiovascular System | 88150-42-9 | Human | R & D |
| Ansofaxine HCl | n.a. | 916918-84-8 | Human | R & D |
| Apabetalone | n.a. | 1044870-39-4 | Human | R & D |
| Apalutamide | L Antineoplastic and Immunomodulating Agents | 956104-40-8 | Human | R & D |
| Apixaban | B Blood and Blood Forming Organs | 503612-47-3 | Human | R & D |
| Apixaban Amorphous | B Blood and Blood forming Organs | 503612-47-3 | Human | R & D |
| Apremilast | L Antineoplastic and Immunomodulating Agents | 608141-41-9 | Human | R & D |
| Aprepitant | A Alimentary Tract and Metabolism | 170729-80-3 | Human | R & D |
| Arformoterol Tartrate | n.a. | 200815-49-2 | Human | R & D |
| Aripiprazole H2O | N Nervous System | 851220-85-4 | Human | R & D |
| Aripiprazole Lauroxil | N Nervous System | 1259305-29-7 | Human | R & D |
| Armodafinil | N Nervous System | 112111-43-0 | Human | R & D |
| Atazanavir | J Antiinfectives for Systemic Use | 198904-31-3 | Human | R & D |
| Atenolol | C Cardiovascular System | 29122-68-7 | Human | R & D |
| Atogepant | N Nervous System | 1374248-81-3 | Human | R & D |
| Atorvastatin | C Cardiovascular System | 134523-00-5 | Human | R & D |
| Atosiban Acetate | G Genito Urinary System and Sex Hormones | 914453-95-5 | Human | R & D |
| Atovaquone | P Antiparasitic Products, Insecticides and Repellents | 95233-18-4 | Human | R & D |
| Avanafil | G Genito Urinary System and Sex Hormones | 330784-47-9 | Human | R & D |
| Avatrombopag | B Blood and Blood forming Organs | 570406-98-3 | Human | R & D |
| Avatrombopag Maleate | B Blood and Blood forming Organs | 677007-74-8 | Human | R & D |
| Axitinib | L Antineoplastic and Immunomodulating Agents | 319460-85-0 | Human | R & D |
| Axitinib Form IV | L Antineoplastic and Immunomodulating Agents | 319460-85-0 | Human | R & D |
| Azacitidine | L Antineoplastic and Immunomodulating Agents | 320-67-2 | Human | R & D |
| Azelnidipine | n.a. | 123524-52-7 | Human | R & D |
| Azilsartan Base | C Cardiovascular System | 147403-03-0 | Human | R & D |
| Azilsartan Kamedoxomil | C Cardiovascular System | 863031-21-4 | Human | R & D |
| Azilsartan Kamedoxomil Form I | C Cardiovascular System | 863031-21-4 | Human | R & D |
| Azilsartan Medoxomil Monopotassium | C Cardiovascular System | 863031-21-4 | Human | R & D |
| Azilsartan Medoxomil Potassium | C Cardiovascular System | 863031-24-7 | Human | R & D |
| Balovaptan | n.a. | 1228088-30-9 | Human | R & D |
| Baloxavir | J Antiinfectives for Systemic Use | 1985605-59-1 | Human | R & D |
| Baloxavir Marboxil | J Antiinfectives for Systemic Use | 1985606-14-1 | Human | R & D |
| Bardoxolone Methyl | n.a. | 218600-53-4 | Human | R & D |
| Baricitinib | L Antineoplastic and Immunomodulating Agents | 1187594-09-7 | Human | R & D |
| Baricitinib Citrate | L Antineoplastic and Immunomodulating Agents | 1187594-09-7 | Human | R & D |
| Bazedoxifene | G Genito Urinary System and Sex Hormones | 198481-32-2 | Human | R & D |
| Bazedoxifene Acetate | G Genito Urinary System and Sex Hormones | 198481-33-3 | Human | R & D |
| Bedaquiline Fumarate | J Antiinfectives for Systemic Use | 845533-86-0 | Human | R & D |
| Belumosudil | L Antineoplastic and Immunomodulating Agents | 911417-87-3 | Human | R & D |
| Belumosudil Mesylate | L Antineoplastic and Immunomodulating Agents | 2109704-99-4 | Human | R & D |
| Bempedoic Acid | C Cardiovascular System | 738606-46-7 | Human | R & D |
| Bendamustine HCl | L Antineoplastic and Immunomodulating Agents | 3543-75-7 | Human | R & D |
| Benfotiamine | A Alimentary Tract and Metabolism | 22457-89-2 | Human | R & D |
| Bensarazide | n.a. | 322-35-0 | Human | R & D |
| Berotralstat HCl | B Blood and Blood Forming Organs | 1809010-52-3 | Human | R & D |
| Betrixaban | B Blood and Blood Forming Organs | 330942-05-7 | Human | R & D |
| Bictegravir | J Antiinfectives for Systemic Use | 1611493-60-7 | Human | R & D |
| Bictegravir Sodium | J Antiinfectives for Systemic Use | 1611493-60-7 | Human | R & D |
| Bilastine | R Respiratory System S Sensory Organs | 202189-78-4 | Human | R & D |
| Binimetinib | L Antineoplastic and Immunomodulating Agents | 606143-89-9 | Human | R & D |
| Bisoprolol | C Cardiovascular System | 66722-44-9 | Human | R & D |
| Blonanserin | n.a. | 132810-10-7 | Human | R & D |
| Bompedoic Acid | C Cardiovascular System | 738606-46-7 | Human | R & D |
| Bortezomib | L Antineoplastic and Immunomodulating Agents | 179324-69-7 | Human | R & D |
| Bosutinib | L Antineoplastic and Immunomodulating Agents | 380843-75-4 | Human | R & D |
| Bosutinib Form I | L Antineoplastic and Immunomodulating Agents | 380843-75-4 | Human | R & D |
| Bosutinib H2O | L Antineoplastic and Immunomodulating Agents | 380843-75-4 | Human | R & D |
| Bremelanotide | G Genito Urinary System and Sex Hormones | 189691-06-3 | Human | R & D |
| Brexanolone | N Nervous System | 516-54-1 | Human | R & D |
| Brexpiprazole | N Nervous System | 913611-97-9 | Human | R & D |
| Brigatinib | L Antineoplastic and Immunomodulating Agents | 1197953-54-0 | Human | R & D |
| Brimonidine | D Dermatologicals | 59803-98-4 | Human | R & D |
| Brimonidine Tartarate | S Sensory Organs | 70359-46-5 | Human | R & D |
| Brinzolamide | S Sensory Organs | 138890-62-7 | Human | R & D |
| Brivaracetam | N Nervous System | 357336-20-0 | Human | R & D |
| Bupivacaine | N Nervous System | 2180-92-9 | Human | R & D |
| Buprenorphine HCl | N Nervous System | 53152-21-9 | Human | R & D |
| Bupropion HCl | N Nervous System | 31677-93-7 | Human | R & D |
| Buspirone HCl | N Nervous System | 33386-08-2 | Human | R & D |
| Busulfan | L Antineoplastic and Immunomodulating Agents | 55-98-1 | Human | R & D |
| Cabazitaxel | L Antineoplastic and Immunomodulating Agents | 183133-96-2 | Human | R & D |
| Cabotegravir | J Antiinfectives for Systemic Use | 1051375-10-0 | Human | R & D |
| Cabotegravir Sodium | J Antiinfectives for Systemic Use | 1051375-13-3 | Human | R & D |
| Cabozantinib | L Antineoplastic and Immunomodulating Agents | 849217-68-1 | Human | R & D |
| Cabozantinib Malate | L Antineoplastic and Immunomodulating Agents | 1140909-48-3 | Human | R & D |
| Cabozantinib S-Malate | L Antineoplastic and Immunomodulating Agents | 1140909-48-3 | Human | R & D |
| Cadazolid | n.a. | 1025097-10-2 | Human | R & D |
| Camostat | B Blood and Blood Forming Organs | 59721-28-7 | Human | R & D |
| Canagliflozin | A Alimentary Tract and Metabolism | 842133-18-0 | Human | R & D |
| Canagliflozin 0.5H2O | A Alimentary Tract and Metabolism | 928672-86-0 | Human | R & D |
| Cangrelor Tetrasodium | B Blood and Blood Forming Organs | 163706-36-3 | Human | R & D |
| Cannabidiol | N Nervous System | 13956-29-1 | Human | R & D |
| Cantharidin | n.a. | 56-25-7 | Human | R & D |
| Capecitabine | L Antineoplastic and Immunomodulating Agents | 154361-50-9 | Human | R & D |
| Capmatinib | L Antineoplastic and Immunomodulating Agents | 1029712-80-8 | Human | R & D |
| Carbozantinib S-Malate | L Antineoplastic and Immunomodulating Agents | 163706-36-3 | Human | R & D |
| Carfilzomib | L Antineoplastic and Immunomodulating Agents | 868540-17-4 | Human | R & D |
| Cariprazine | N Nervous System | 839712-12-8 | Human | R & D |
| Carmustine | L Antineoplastic and Immunomodulating Agents | 154-93-8 | Human | R & D |
| Carvedilol | C Cardiovascular System | 72956-09-3 | Human | R & D |
| Caspofungin | J Antiinfectives for Systemic Use | 162808-62-0 | Human | R & D |
| Cedazuridine | n.a. | 1141397-80-9 | Human | R & D |
| Cefaclor | J Antiinfectives for Systemic Use | 53994-73-3 | Human | R & D |
| Cefadroxil | J Antiinfectives for Systemic Use | 50370-12-2 | Human | R & D |
| Cefovecin | J Antiinfectives for Systemic Use | 234096-34-5 | Vet | R & D |
| Celecoxib | L Antineoplastic and Immunomodulating Agents M Musculo-Sekeletal System | 169590-42-5 | Human | R & D |
| Cenobamate | N Nervous System | 913088-80-9 | Human | R & D |
| Cephalexin | J Antiinfectives for Systemic Use | 15686-71-2 | Human | R & D |
| Cetilistat | n.a. | 282526-98-1 | Human | R & D |
| Chlortalidone | C Cardiovascular System | 77-36-1 | Human | R & D |
| Chlorzoxazone | M Musculo-Sekeletal System | 95-25-0 | Human | R & D |
| Cilostazol | B Blood and Blood Forming Organs | 73963-72-1 | Human | R & D |
| Cinacalcet HCl | H Systemic Hormonal Preperations, excl. Sex Hormones and Insulins | 364782-34-3 | Human | R & D |
| Citicoline Sodium | N Nervous System | 33818-15-4 | Human | R & D |
| Cladribine | L Antineoplastic and Immunomodulating Agents | 4291-63-8 | Human | R & D |
| Clascoterone | D Dermatologicals | 19608-29-8 | Human | R & D |
| Clevidipine | C Cardiovascular System | 167221-71-8 | Human | R & D |
| Clobazam | N Nervous System | 22316-47-8 | Human | R & D |
| Cobicistat | V Various | 1004316-88-4 | Human | R & D |
| Copanlisib HCl | L Antineoplastic and Immunomodulating Agents | 1402152-13-9 | Human | R & D |
| Corticotropin Acetate | H Systemic Hormonal Preperations, excl. Sex Hormones and Insulins | 12427-33-7 | Human | R & D |
| Crisaborole | D Dermatologicals | 906673-24-3 | Human | R & D |
| Crizotinib | L Antineoplastic and Immunomodulating Agents | 877399-52-5 | Human | R & D |
| Cyclobenzaprine | M Musculo-Sekeletal System | 303-53-7 | Human | R & D |
| Dabigatran | B Blood and Blood Forming Organs | 211914-51-1 | Human | R & D |
| Dabigatran Etexilate | B Blood and Blood Forming Organs | 211915-06-9 | Human | R & D |
| Dabigatran Etexilate Mesylate | B Blood and Blood forming Organs | 872728-81-9 | Human | R & D |
| Dabigatran Mesylate | B Blood and Blood forming Organs | 872728-81-9 | Human | R & D |
| Dacomitinib | L Antineoplastic and Immunomodulating Agents | 1110813-31-4 | Human | R & D |
| Dapagliflozin | A Alimentary Tract and Metabolism | 461432-26-8 | Human | R & D |
| Dapagliflozin Amorphous | A Alimentary Tract and Metabolism | 461432-26-8 | Human | R & D |
| Dapagliflozin Premix | A Alimentary Tract and Metabolism | 461432-26-8 | Human | R & D |
| Dapagliflozin Propanediol H2O | A Alimentary Tract and Metabolism | 960404-48-2 | Human | R & D |
| Dapagliflozin SPG Solvate | A Alimentary Tract and Metabolism | 461432-26-8 | Human | R & D |
| Dapoxetine HCl | G Genito Urinary System and Sex Hormones | 129938-20-1 | Human | R & D |
| Daprodustat | B Blood and Blood Forming Organs | 960539-70-2 | Human | R & D |
| Darifenacin HBr | G Genito Urinary System and Sex Hormones | 133099-07-7 | Human | R & D |
| Darolutamide | L Antineoplastic and Immunomodulating Agents | 1297538-32-9 | Human | R & D |
| Darunavir | J Antiinfectives for Systemic Use | 206361-99-1 | Human | R & D |
| Darunavir Amorphous | J Antiinfectives for Systemic Use | 206361-99-1 | Human | R & D |
| Dasatinib | L Antineoplastic and Immunomodulating Agents | 302962-49-8 | Human | R & D |
| Dasatinib H2O | L Antineoplastic and Immunomodulating Agents | 302962-49-8 | Human | R & D |
| Deflazacort | H Systemic Hormonal Preperations, excl. Sex Hormones and Insulins | 14484-47-0 | Human | R & D |
| Degarelix Acetate | L Antineoplastic and Immunomodulating Agents | 934016-19-0 | Human | R & D |
| Dehydrated Alcohol | D Dermatologicals | 64-17-5 | Human | R & D |
| Delamanid | J Antiinfectives for Systemic Use | 681492-22-8 | Human | R & D |
| Desvenlafaxine Benzoate | N Nervous System | 1147940-37-1 | Human | R & D |
| Desvenlafaxine Succinate | N Nervous System | 386750-22-7 | Human | R & D |
| Desvenlafaxine Succinate H2O | N Nervous System | 386750-22-7 | Human | R & D |
| Deucravitnib | L Antineoplastic and Immunomodulating Agents | 1609392-27-9 | Human | R & D |
| Deuterated Tetrabenazine | N Nervous System | 1392826-25-3 | Human | R & D |
| Deutetrabenazine | N Nervous System | 1392826-25-3 | Human | R & D |
| Dexlansoprazole | A Alimentary Tract and Metabolism | 138530-94-6 | Human | R & D |
| Dexmethylfendinate | N Nervous System | 40431-64-9 | Human | R & D |
| Dextromethorphan | R Respiratory System | 125-71-3 | Human | R & D |
| Dextromethorphan HBr H2O | N Nervous System | 6700-34-1 | Human | R & D |
| Diltiazem | C Cardiovascular System | 42399-41-7 | Human | R & D |
| Dimethyl Fumarate | L Antineoplastic and Immunomodulating Agents | 624-49-7 | Research | R & D |
| Diphenhydramine | D Dermatologicals R Respiratory System | 0016503-7 | Human | R & D |
| Diroximel Fumarate | L Antineoplastic and Immunomodulating Agents | 1577222-14-0 | Human | R & D |
| Dolutegravir | J Antiinfectives for Systemic Use | 1051375-16-6 | Human | R & D |
| Dolutegravir Sodium | J Antiinfectives for Systemic Use | 1051375-19-9 | Human | R & D |
| Doravirine | J Antiinfectives for Systemic Use | 1338225-97-0 | Human | R & D |
| DOTAP | n.a. | n.a. | Research | R & D |
| Doxycycline H2O | A Alimentary Tract and Metabolism J Antiinfectives for Systemic Use | 17086-28-1 | Human | R & D |
| Doxycycline Hyclate | A Alimentary Tract and Metabolism J Antiinfectives for Systemic Use | 24390-14-5 | Human | R & D |
| Doxylamine Succinate | R Respiratory System | 562-10-7 | Human | R & D |
| Drospirenone | G Genito Urinary System and Sex Hormones | 67392-87-4 | Human | R & D |
| Duloxetine | N Nervous System | 116539-59-4 | Human | R & D |
| Duvelisib | L Antineoplastic and Immunomodulating Agents | 1201438-56-3 | Human | R & D |
| Dydrogesterone | G Genito Urinary System and Sex Hormones | 152-62-5 | Human | R & D |
| Edaravone | N Nervous System | 89-25-8 | Human | R & D |
| Edoxaban | B Blood and Blood Forming Organs | 480449-70-5 | Human | R & D |
| Edoxaban Tosylate | B Blood and Blood Forming Organs | 480449-71-6 | Human | R & D |
| Efinaconazole | D Dermatologicals | 164650-44-6 | Human | R & D |
| Elagolix | H Systemic Hormonal Preperations, excl. Sex Hormones and Insulins | 832720-36-2 | Human | R & D |
| Elagolix Sodium | H Systemic Hormonal Preperations, excl. Sex Hormones and Insulins | 832720-36-2 | Human | R & D |
| Elexacaftor | R Respiratory System | 2216712-66-0 | Human | R & D |
| Eliglustat Hemitartrate | A Alimentary Tract and Metabolism | 928659-70-5 | Human | R & D |
| Eliglustat Tartrate | A Alimentary Tract and Metabolism | 928659-70-5 | Human | R & D |
| Eltrombopag | B Blood and Blood Forming Organs | 496775-61-2 | Human | R & D |
| Eltrombopag Olamine | B Blood and Blood Forming Organs | 496775-62-3 | Human | R & D |
| Eluxadoline | A Alimentary Tract and Metabolism | 864821-90-9 | Human | R & D |
| Elvitegravir | J Antiinfectives for Systemic Use | 697761-98-1 | Human | R & D |
| Elvitegravir Form III | J Antiinfectives for Systemic Use | 697761-98-1 | Human | R & D |
| Empagliflozin | A Alimentary Tract and Metabolism | 864070-44-0 | Human | R & D |
| Empagliflozin Amorphous | A Alimentary Tract and Metabolism | 864070-44-0 | Human | R & D |
| Empagliflozin Crystalline | A Alimentary Tract and Metabolism | 1210344-83-4 | Human | R & D |
| Emtricitabine | J Antiinfectives for Systemic Use | 143491-57-0 | Human | R & D |
| Enasidenib | L Antineoplastic and Immunomodulating Agents | 1446502-11-9 | Human | R & D |
| Enasidenib Mesylate | L Antineoplastic and Immunomodulating Agents | 1650550-25-6 | Human | R & D |
| Encorafenib | L Antineoplastic and Immunomodulating Agents | 1269440-17-6 | Human | R & D |
| Entrectinib | L Antineoplastic and Immunomodulating Agents | 1108743-60-7 | Human | R & D |
| Enzalutamide | L Antineoplastic and Immunomodulating Agents | 915087-33-1 | Human | R & D |
| Epacadostat | L Antineoplastic and Immunomodulating Agents | 1204669-58-8 | Human | R & D |
| Epinephrine | A Alimentary Tract and Metabolism B Blood and Blood Forming Organs C Cardiovascular System R Respiratory System S Sensory Organs | 51-43-4 | Human | R & D |
| Epinephrine Bitartrate | A Alimentary Tract and Metabolism B Blood and Blood Forming Organs C Cardiovascular System R Respiratory System S Sensory Organs | 51-42-3 | Human | R & D |
| Eplerelone | C Cardiovascular System | 107724-20-9 | Human | R & D |
| Eprosartan Mesylate | C Cardiovascular System | 144143-96-4 | Human | R & D |
| Erdafitinib | L Antineoplastic and Immunomodulating Agents | 1346242-81-6 | Human | R & D |
| Eribulin | L Antineoplastic and Immunomodulating Agents | 253128-41-5 | Human | R & D |
| Erlotinib | L Antineoplastic and Immunomodulating Agents | 183321-74-6 | Human | R & D |
| Ertugliflozin | A Alimentary Tract and Metabolism | 1210344-57-2 | Human | R & D |
| Ertugliflozin L-Pyroglutamic Acid | A Alimentary Tract and Metabolism | 1210344-57-2 | Human | R & D |
| Erythopoietin | B Blood and Blood Forming Organs | 11096-26-7 | Human | R & D |
| Erythromycin Ethyl Succinate | J Antiinfectives for Systemic Use | 1264-62-6 | Human | R & D |
| Escitalopram Oxalate | N Nervous System | 219861-08-2 | Human | R & D |
| Eslicarbazepine | N Nervous System | 104746-04-5 | Human | R & D |
| Estriol | G Genito Urinary System and Sex Hormones | 50-27-1 | Human | R & D |
| Ethambutol | J Antiinfectives for Systemic Use | 74-55-5 | Human | R & D |
| Ethinyl Estradiol | G Genito Urinary System and Sex Hormones | 57-63-6 | Human | R & D |
| Etravirine | J Antiinfectives for Systemic Use | 269055-15-4 | Human | R & D |
| Etravirine Form I | J Antiinfectives for Systemic Use | 269055-15-4 | Human | R & D |
| Evobrutinib | L Antineoplastic and Immunomodulating Agents | 1415823-73-2 | Human | R & D |
| Ezetimibe | C Cardiovascular System | 163222-33-1 | Human | R & D |
| Febuxostat | M Musculo-Sekeletal System | 144060-53-7 | Human | R & D |
| Febuxostat Form A | M Musculo-Sekeletal System | 144060-53-7 | Human | R & D |
| Fedratinib | L Antineoplastic and Immunomodulating Agents | 936091-26-8 | Human | R & D |
| Fenfluramine HCl | A Alimentary Tract and Metabolism N Nervous System | 404-82-0 | Human | R & D |
| Fenofibrate | C Cardiovascular System | 49562-28-9 | Human | R & D |
| Fenretinide | n.a. | 65646-68-6 | Human | R & D |
| Fenticonazole | G Genito Urinary System and Sex Hormones D Dermatologicals | 72479-26-6 | Human | R & D |
| Fenticonazole Nitrate | G Genito Urinary System and Sex Hormones D Dermatologicals | 73151-29-8 | Human | R & D |
| Ferric Carboxymaltose | B Blood and Blood Forming Organs | 9007-72-1 | Human | R & D |
| Ferric Maltol | B Blood and Blood Forming Organs | 33725-54-1 | Human | R & D |
| Ferrous Ascorbate | B Blood and Blood Forming Organs | 24808-52-4 | Human | R & D |
| Ferumoxytol | B Blood and Blood Forming Organs | 722492-56-0 | Human | R & D |
| Fesoterodine Fumarate | G Genito Urinary System and Sex Hormones | 286930-03-8 | Human | R & D |
| Fexofenadine | R Respiratory System | 83799-24-0 | Human | R & D |
| Fezolinetant | G Genito Urinary System and Sex Hormones | 1629229-37-3 | Human | R & D |
| Filgotinib Maleate | D Dermatologicals | 1802998-75-9 | Human | R & D |
| Finerenone | C Cardiovascular System | 1050477-31-0 | Human | R & D |
| Fingolimod HCl | L Antineoplastic and Immunomodulating Agents | 162359-56-0 | Human | R & D |
| Flibanserin | G Genito Urinary System and Sex Hormones | 167933-07-5 | Human | R & D |
| Flumethrin | P Antiparasitic Products, Insecticides and Repellents | 69770-45-2 | Vet | R & D |
| Fluralaner | P Antiparasitic Products, Insecticides and Repellents | 864731-61-3 | Vet | R & D |
| Fluvoxamine Maleate | N Nervous System | 61718-82-9 | Human | R & D |
| Folic Acid | B Blood and Blood Forming Organs V Various | 59-30-3 | Human | R & D |
| Formoterol Fumarate | R Respiratory System | 43229-80-7 | Human | R & D |
| Fosaprepitant | A Alimentary Tract and Metabolism | 172673-20-0 | Human | R & D |
| Fostamatinib | B Blood and Blood forming Organs | 901119-35-5 | Human | R & D |
| Fostamatinib Disodium | B Blood and Blood Forming Organs | 1025687-58-4 | Human | R & D |
| Fostemsavir | J Antiinfectives for Systemic Use | 864953-29-7 | Human | R & D |
| Gabapentin | N Nervous System | 60142-96-3 | Human | R & D |
| Gamithromycin | J Antiinfectives for Systemic Use | 145435-72-9 | Vet | R & D |
| Ganaxolone | N Nervous System | 38398-32-2 | Human | R & D |
| Gefapixant | R Respiratory System | 1015787-98-0 | Human | R & D |
| Gilteritinib | L Antineoplastic and Immunomodulating Agents | 1254053-43-4 | Human | R & D |
| Giredestrant | n.a. | 1953133-47-5 | Human | R & D |
| Glacial Acetic Acid | G Genito Urinary System and Sex Hormones | 64-19-7 | Research | R & D |
| Glasdegib | L Antineoplastic and Immunomodulating Agents | 1095173-27-5 | Human | R & D |
| Glatiramer Acetate | L Antineoplastic and Immunomodulating Agents | 386750-22-7 | Human | R & D |
| Glipizide | A Alimentary Tract and Metabolism | 29094-61-9 | Human | R & D |
| Glucagon Acetate | H Systemic Hormonal Preperations, excl. Sex Hormones and Insulins | 16941-32-5 | Human | R & D |
| Glycopyrrolate | A Alimentary Tract and Metabolism D Dermatologicals R Respiratory System | 596-51-0 | Human | R & D |
| Glycopyrrolate Tosylate | A Alimentary Tract and Metabolism D Dermatologicals R Respiratory System | 1624259-25-1 | Human | R & D |
| Grapiprant | M Musculo-Sekeletal System | 415903-37-6 | Vet | R & D |
| Guadecitabine | n.a. | 929901-49-5 | Human | R & D |
| Guaifenesin | R Respiratory System | 93-14-1 | Human | R & D |
| Guanfacine HCl | C Cardiovascular System | 29110-48-3 | Human | R & D |
| Hydralazine | C Cardiovascular System | 19774-82-4 | Human | R & D |
| Hydrochlorothiazide | C Cardiovascular System | 58-93-5 | Human | R & D |
| Hydroxychloroquine Sulphate | N Nervous System | 747-36-4 | Human | R & D |
| Hydroxyzine HCl | N Nervous System | 2192-20-3 | Human | R & D |
| Hydroxyzine Pamoate | N Nervous System | 10246-75-0 | Human | R & D |
| Ibrexafungerp | J Antiinfectives for Systemic Use | 1207753-03-4 | Human | R & D |
| Ibrutinib | L Antineoplastic and Immunomodulating Agents | 936563-96-1 | Human | R & D |
| Idelalisib | L Antineoplastic and Immunomodulating Agents | 870281-82-6 | Human | R & D |
| Imatinib Mesylate | L Antineoplastic and Immunomodulating Agents | 220127-57-1 | Human | R & D |
| Imeglimin | A Alimentary Tract and Metabolism C Cardiovascular System | 58-93-5 | Human | R & D |
| Indacaterol Acetate | R Respiratory System | 1000160-96-2 | Human | R & D |
| Indacaterol Maleate | R Respiratory System | 753498-25-8 | Human | R & D |
| Indocyanine Green | V Various | 3599-32-4 | Human | R & D |
| Infigratinib Phosphate | L Antineoplastic and Immunomodulating Agents | 1310746-10-1 | Human | R & D |
| Ipragliflozin | A Alimentary Tract and Metabolism | 761423-87-4 | Human | R & D |
| Irbesartan | C Cardiovascular System | 138402-11-6 | Human | R & D |
| Irinotecan | L Antineoplastic and Immunomodulating Agents | 97682-44-5 | Human | R & D |
| Isavuconazol | J Antiinfectives for Systemic Use | 241479-67-4 | Human | R & D |
| Isavuconazonium Sulphate | J Antiinfectives for Systemic Use | 946075-13-4 | Human | R & D |
| Isavuconozonium | J Antiinfectives for Systemic Use | 742049-41-8 | Human | R & D |
| Islatravir | n.a. | 865363-93-5 | Human | R & D |
| Isosulfan Blue | n.a. | 68238-36-8 | Human | R & D |
| Ivabradine HCl | C Cardiovascular System | 148849-67-6 | Human | R & D |
| Ivacaftor | R Respiratory System | 873054-44-5 | Human | R & D |
| Ivosidenib | L Antineoplastic and Immunomodulating Agents | 1448347-49-6 | Human | R & D |
| Ixazomib | L Antineoplastic and Immunomodulating Agents | 1072833-77-2 | Human | R & D |
| Ixazomib Citrate | L Antineoplastic and Immunomodulating Agents | 1239908-20-3 | Human | R & D |
| Ketamine | N Nervous System | 6740-88-1 | Human | R & D |
| Ketorolac Tromethamine | S Sensory Organs | 74103-06-3 | Human | R & D |
| Labetalol | C Cardiovascular System | 36894-69-6 | Human | R & D |
| Labetalol HCl | C Cardiovascular System | 32780-64-6 | Human | R & D |
| Lacosamide | N Nervous System | 175481-36-4 | Human | R & D |
| Lactulose | A Alimentary Tract and Metabolism | 4618-18-2 | Human | R & D |
| Laninamivir Octanoate | J Antiinfectives for Systemic Use | 203120-46-1 | Human | R & D |
| Lanreotide Acetate | H Systemic Hormonal Preperations, excl. Sex Hormones and Insulins | 127984-74 | Human | R & D |
| Larotrectinib | L Antineoplastic and Immunomodulating Agents | 1223403-58-4 | Human | R & D |
| Larotrectinib Sulphate | L Antineoplastic and Immunomodulating Agents | 1223403-58-4 | Human | R & D |
| Lasmiditan | N Nervous System | 439239-90-4 | Human | R & D |
| Lasmiditan Hemisuccinate | N Nervous System | 439239-92-6 | Human | R & D |
| Lasmiditan Succinate | N Nervous System | 439239-92-6 | Human | R & D |
| Ledipasvir | J Antiinfectives for Systemic Use | 1256388-51-8 | Human | R & D |
| Lemborexant | N Nervous System | 1369764-02-2 | Human | R & D |
| Lenalidomide | L Antineoplastic and Immunomodulating Agents | 191732-72-6 | Human | R & D |
| Lenalidomide Form B | L Antineoplastic and Immunomodulating Agents | 191732-72-6 | Human | R & D |
| Lenvatinib | L Antineoplastic and Immunomodulating Agents | 417716-92-8 | Human | R & D |
| Lenvatinib Mesylate | L Antineoplastic and Immunomodulating Agents | 857890-39-2 | Human | R & D |
| Lenvatinib Mesylate Form C | L Antineoplastic and Immunomodulating Agents | 857890-39-2 | Human | R & D |
| Lenvatinib Mesylate Form M | L Antineoplastic and Immunomodulating Agents | 857890-39-2 | Human | R & D |
| Lesinurad | M Musculo-Sekeletal System | 878672-00-5 | Human | R & D |
| Lesinurad Sodium | M Musculo-Sekeletal System | 1151516-14-1 | Human | R & D |
| Letermovir | J Antiinfectives for Systemic Use | 917389-32-3 | Human | R & D |
| Levetiracetam | N Nervous System | 102767-28-2 | Human | R & D |
| Levobupivacaine HCl | N Nervous System | 27262-48-2 | Human | R & D |
| Levomilnacipran HCl | N Nervous System | 175131-60-9 | Human | R & D |
| Levosimendan | C Cardiovascular System | 141505-33-1 | Human | R & D |
| Levothyroxine | H Systemic Hormonal Preperations, excl. Sex Hormones and Insulins | 51-48-9 | Human | R & D |
| Lifitegrast | S Sensory Organs | 1025967-78-5 | Human | R & D |
| Linaclotide | A Alimentary Tract and Metabolism | 851199-59-2 | Human | R & D |
| Linaclotide Acetate | A Alimentary Tract and Metabolism | 851199-60-5 | Human | R & D |
| Linagliptin | A Alimentary Tract and Metabolism | 668270-12-0 | Human | R & D |
| Linagliptin Form C | A Alimentary Tract and Metabolism | 846589-98-8 | Human | R & D |
| Linzagolix | H Systemic Hormonal Preperations, excl. Sex Hormones and Insulins | 935283-04-8 | Human | R & D |
| Liraglutide | A Alimentary Tract and Metabolism | 204656-20-2 | Human | R & D |
| Liraglutide Acetate | A Alimentary Tract and Metabolism | 204656-20-2 | Human | R & D |
| Lisinopril | C Cardiovascular System | 76547-98-3 | Human | R & D |
| lndacoterol Acetate | R Respiratory System | 1000160-96-2 | Human | R & D |
| Lofexidine | N Nervous System | 31036-80-3 | Human | R & D |
| Lopinavir | J Antiinfectives for Systemic Use | 192725-17-0 | Human | R & D |
| Lorcaserin HCI | A Alimentary Tract and Metabolism | 846589-98-8 | Human | R & D |
| Lorlatinib | L Antineoplastic and Immunomodulating Agents | 1454846-35-5 | Human | R & D |
| Losartan | C Cardiovascular System | 114798-26-4 | Human | R & D |
| Losartan Potassium | C Cardiovascular System | 124750-99-8 | Human | R & D |
| Luliconazole | D Dermatologicals | 187164-19-8 | Human | R & D |
| Lumacaftor | R Respiratory System | 936727-05-8 | Human | R & D |
| Lumateperone Tosylate | N Nervous System | 313368-91-1 | Human | R & D |
| Lurasidone | N Nervous System | 367514-87-2 | Human | R & D |
| Lurasidone HCl | N Nervous System | 367514-88-3 | Human | R & D |
| Lurbinectedin | L Antineoplastic and Immunomodulating Agents | 497871-47-3 | Human | R & D |
| Lusutrombopag | B Blood and Blood Forming Organs | 1110766-97-6 | Human | R & D |
| Macitentan | C Cardiovascular System | 441798-33-0 | Human | R & D |
| Maraviroc | J Antiinfectives for Systemic Use | 376348-65-1 | Human | R & D |
| Maraviroc Potassium | J Antiinfectives for Systemic Use | 376348-65-1 | Human | R & D |
| Maraviroc Potassium Amorphous | J Antiinfectives for Systemic Use | 376348-65-1 | Human | R & D |
| Maraviroc Potassium Form B | J Antiinfectives for Systemic Use | 376348-65-1 | Human | R & D |
| Marbofloxacin | J Antiinfectives for Systemic Use | 115550-35-1 | Vet | R & D |
| Mavacamten | C Cardiovascular System | 1642288-47-8 | Human | R & D |
| Meclizine HCl | R Respiratory System | 1104-22-9 | Human | R & D |
| Melengestrol Acetate | n.a. | 2919-66-6 | Vet | R & D |
| Memantine | N Nervous System | 19982-08-2 | Human | R & D |
| Mesalamine | A Alimentary Tract and Metabolism | 89-57-6 | Human | R & D |
| Mesalazine | A Alimentary Tract and Metabolism | 89-57-6 | Human | R & D |
| Methocarbamol | M Musculo-Sekeletal System | 532-03-6 | Human | R & D |
| Methotrexate | L Antineoplastic and Immunomodulating Agents | 59-05-2 | Human | R & D |
| Methylene Blue | V Various | 61-73-4 | Human | R & D |
| Metoprolol Succinate | C Cardiovascular System | 98418-47-4 | Human | R & D |
| Metyrosine | C Cardiovascular System | 672-87-7 | Human | R & D |
| Micafungin | J Antiinfectives for Systemic Use | 235114-32-6 | Human | R & D |
| Midostaurin | L Antineoplastic and Immunomodulating Agents | 120685-11-2 | Human | R & D |
| Migalastat HCl | A Alimentary Tract and Metabolism | 75172-81-5 | Human | R & D |
| Miglustat | A Alimentary Tract and Metabolism | 72599-27-0 | Human | R & D |
| Milnacipran HCl | N Nervous System | 101152-94-7 | Human | R & D |
| Milrinone Lactate | C Cardiovascular System | 100286-97-3 | Human | R & D |
| Mirabegron | G Genito Urinary System and Sex Hormones | 223673-61-8 | Human | R & D |
| Mirabegron Alpha Form | G Genito Urinary System and Sex Hormones | 223673-61-8 | Human | R & D |
| Mirogabalin | N Nervous System | 1138245-13-2 | Human | R & D |
| Mirogabalin Besylate | N Nervous System | 1138245-13-2 | Human | R & D |
| Mitavipat | B Blood and Blood Forming Organs | 1260075-17-9 | Human | R & D |
| Molnupiravir | J Antiinfectives for Systemic Use | 2492423-29-5 | Human | R & D |
| Montelukast Sodium | R Respiratory System | 151767-02-1 | Human | R & D |
| Mycophenolate Sodium | L Antineoplastic and Immunomodulating Agents | 37415-62-6 | Human | R & D |
| Nafamostat Mesylate | n.a. | 82956-11-4 | Human | R & D |
| Naftifine | D Dermatologicals | 65472-88-0 | Human | R & D |
| Naloxegol Oxalate | A Alimentary Tract and Metabolism | 1354744-91-4 | Human | R & D |
| Naproxen Sodium | G Genito Urinary System and Sex Hormones | 26159-34-2 | Human | R & D |
| Nebivolol | C Cardiovascular System | 118457-14-0 | Human | R & D |
| Nebivolol HCl | C Cardiovascular System | 152520-56-4 | Human | R & D |
| Nefazodone | N Nervous System | 83366-66-9 | Human | R & D |
| Nelarabine | L Antineoplastic and Immunomodulating Agents | 121032-29-9 | Human | R & D |
| Neratinib | L Antineoplastic and Immunomodulating Agents | 698387-09-6 | Human | R & D |
| Netarsudil Dimesylate | S Sensory Organs | 1422144-42-0 | Human | R & D |
| Nicardipine HCl | C Cardiovascular System | 54527-84-3 | Human | R & D |
| Nicorandil | C Cardiovascular System | 65141-46-0 | Human | R & D |
| Nifedipine | C Cardiovascular System | 21829-25-4 | Human | R & D |
| Nilotinib | L Antineoplastic and Immunomodulating Agents | 641571-10-0 | Human | R & D |
| Nilotinib Fumarate | L Antineoplastic and Immunomodulating Agents | 1304125-88-9 | Human | R & D |
| Nilotinib HCl | L Antineoplastic and Immunomodulating Agents | 923288-95-3 | Human | R & D |
| Nilotinib Tartrate | L Antineoplastic and Immunomodulating Agents | 1353151-37-7 | Human | R & D |
| Nintedanib | L Antineoplastic and Immunomodulating Agents | 656247-17-5 | Human | R & D |
| Nintedanib Esylate | L Antineoplastic and Immunomodulating Agents | 656247-18-6 | Human | R & D |
| Nintedanib Esylate 0.5H2O | L Antineoplastic and Immunomodulating Agents | 656247-18-6 | Human | R & D |
| Niraparib Tosylate | L Antineoplastic and Immunomodulating Agents | 1038915-73-9 | Human | R & D |
| Nirmatrelvir | n.a. | 2628280-40-8 | Human | R & D |
| Nitrofurantoin Macrocrystal | J Antiinfectives for Systemic Use | 67-20-10 | Human | R & D |
| Noradrenaline Bitartrate | C Cardiovascular System | 51-40-1 | Human | R & D |
| Norepinephrine Bitartrate | C Cardiovascular System | 69815-49-2 | Human | R & D |
| Obeticholic Acid | A Alimentary Tract and Metabolism | 459789-99-2 | Human | R & D |
| Octenidine | R Respiratory System | 70775-75-6 | Human | R & D |
| Olaparib | L Antineoplastic and Immunomodulating Agents | 763113-22-0 | Human | R & D |
| Olaparib Form A | L Antineoplastic and Immunomodulating Agents | 763113-22-0 | Human | R & D |
| Olaparib Form H | L Antineoplastic and Immunomodulating Agents | 763113-22-0 | Human | R & D |
| Olmesartan | C Cardiovascular System | 144689-24-7 | Human | R & D |
| Olmesartan Medoximil | c Cardiovascular System | 144689-63-4 | Human | R & D |
| Olodaterol | R Respiratory System | 868049-49-4 | Human | R & D |
| Olodaterol HCl | R Respiratory System | 869477-96-3 | Human | R & D |
| Omadacycline | J Antiinfectives for Systemic Use | 389139-89-3 | Human | R & D |
| Opicapone | N Nervous System | 923287-50-7 | Human | R & D |
| Osimertinib | L Antineoplastic and Immunomodulating Agents | 1421373-65-0 | Human | R & D |
| Osimertinib Mesylate | L Antineoplastic and Immunomodulating Agents | 1421373-66-1 | Human | R & D |
| Ospemifene | G Genito Urinary System and Sex Hormones | 128607-22-7 | Human | R & D |
| Oteseconazole | J Antiinfectives for Systemic Use | 1340593-59-0 | Human | R & D |
| Oxcarbazepine | N Nervous System | 28721-07-5 | Human | R & D |
| Ozanimod HCl | L Antineoplastic and Immunomodulating Agents | 1618636-37-5 | Human | R & D |
| Ozenoxacin | D Dermatologicals | 245765-41-7 | Human | R & D |
| Palbociclib | L Antineoplastic and Immunomodulating Agents | 571190-30-2 | Human | R & D |
| Paliperidone | N Nervous System | 144598-75-4 | Human | R & D |
| Pancrelipase | A Alimentary Tract and Metabolism | 53608-75-6 | Human | R & D |
| Pantoprazole Sodium | A Alimentary Tract and Metabolism | 138786-67-1 | Human | R & D |
| Patiromer Calcium Sorbitex | V Various | 1260645-52-4 | Human | R & D |
| Pazopanib | L Antineoplastic and Immunomodulating Agents | 444731-52-6 | Human | R & D |
| Pazopanib HCl | L Antineoplastic and Immunomodulating Agents | 635702-64-6 | Human | R & D |
| Peficitinib | L Antineoplastic and Immunomodulating Agents | 944118-01-8 | Human | R & D |
| Pemetrexed | L Antineoplastic and Immunomodulating Agents | 137281-23-3 | Human | R & D |
| Pemigatinib | L Antineoplastic and Immunomodulating Agents | 1513857-77-6 | Human | R & D |
| Perampanel | N Nervous System | 380917-97-5 | Human | R & D |
| Pergolide | N Nervous System | 66104-22-1 | Vet | R & D |
| Permethrine | P Antiparasitic Products, Insecticides and Repellents | 52645-53-1 | Human | R & D |
| Phenylephrine | C Cardiovascular System R Respiratory System S Sensory Organs | 59-42-7 | Human | R & D |
| Pimavanserin | N Nervous System | 706779-91-1 | Human | R & D |
| Pimavanserin Hemitartrate | N Nervous System | 706782-28-7 | Human | R & D |
| Pimavanserin Tartrate | N Nervous System | 706782-28-7 | Human | R & D |
| Pinaverium Br | A Alimentary Tract and Metabolism | 53251-94-8 | Human | R & D |
| Pioglitazone | A Alimentary Tract and Metabolism | 111025-46-8 | Human | R & D |
| Pirfenidone | L Antineoplastic and Immunomodulating Agents | 53179-13-8 | Human | R & D |
| Pitavastatin Calcium | C Cardiovascular System | 147526-32-7 | Human | R & D |
| Pitolisant | N Nervous System | 362665-56-3 | Human | R & D |
| Pitolisant HCl | N Nervous System | 903576-44-3 | Human | R & D |
| Plerixafor | L Antineoplastic and Immunomodulating Agents | 110078-46-1 | Human | R & D |
| Plinabulin | n.a. | 714272-27-2 | Human | R & D |
| Pomalidomide | L Antineoplastic and Immunomodulating Agents | 19171-19-8 | Human | R & D |
| Pomalidomide Form A | L Antineoplastic and Immunomodulating Agents | 19171-19-8 | Human | R & D |
| Ponatinib | L Antineoplastic and Immunomodulating Agents | 943319-70-8 | Human | R & D |
| Ponatinib HCl | L Antineoplastic and Immunomodulating Agents | 1114544-31-8 | Human | R & D |
| Posaconazole | A Alimentary Tract and Metabolism J Antiinfectives for Systemic Use | 171228-49-2 | Human | R & D |
| Posaconazole Form I | A Alimentary Tract and Metabolism J Antiinfectives for Systemic Use | n.a. | Human | R & D |
| Pralsetinib | L Antineoplastic and Immunomodulating Agents | 2097132-94-8 | Human | R & D |
| Pramipexole 2HCl H2O | n.a. | 191217-81-9 | Human | R & D |
| Prednisolone Acetate | S Sensory Organs | 52-21-1 | Human | R & D |
| Pretomanid | J Antiinfectives for Systemic Use | 187235-37-6 | Human | R & D |
| Primidone | N Nervous System | 125-33-7 | Human | R & D |
| Propanolol | C Cardiovascular System | 525-66-6 | Human | R & D |
| Propofol | N Nervous System | 2078-54-8 | Human | R & D |
| Prucalopride Succinate | A Alimentary Tract and Metabolism | 179474-85-2 | Human | R & D |
| Pyrazinamide | J Antiinfectives for Systemic Use | 98-96-4 | Human | R & D |
| Pyridostigmine Br | N Nervous System | 101-26-8 | Human | R & D |
| Pyrotinib Maleate | L Antineoplastic and Immunomodulating Agents | 1397922-61-0 | Human | R & D |
| Quetiapine Fumarate | N Nervous System | 111974-72-2 | Human | R & D |
| Ralinepag | n.a. | 1187856-49-0 | Human | R & D |
| Raloxifene | G Genito Urinary System and Sex Hormones | 84449-90-1 | Human | R & D |
| Raloxifene HCl | G Genito Urinary System and Sex Hormones | 82640-04-8 | Human | R & D |
| Raltegravir | J Antiinfectives for Systemic Use | 518048-05-0 | Human | R & D |
| Raltegravir Form I | J Antiinfectives for Systemic Use | 871038-72-1 | Human | R & D |
| Raltegravir Form III | J Antiinfectives for Systemic Use | 518048-05-0 | Human | R & D |
| Raltegravir Potassium | J Antiinfectives for Systemic Use | 871038-72-1 | Human | R & D |
| Raltegravir Potassium Form III | J Antiinfectives for Systemic Use | 871038-72-1 | Human | R & D |
| Ranolazine | C Cardiovascular System | 95635-55-5 | Human | R & D |
| Regadenoson | C Cardiovascular System | 313348-27-5 | Human | R & D |
| Regadenoson Anhydrous | C Cardiovascular System | 313348-27-5 | Human | R & D |
| Regadenoson H2O | C Cardiovascular System | 875148-45-1 | Human | R & D |
| Regorafenib | L Antineoplastic and Immunomodulating Agents | 755037-03-7 | Human | R & D |
| Relebactam | J Antiinfectives for Systemic Use | 1174018-99-5 | Human | R & D |
| Relugolix | L Antineoplastic and Immunomodulating Agents | 737789-87-6 | Human | R & D |
| Remdesivir | J Antiinfectives for Systemic Use | 1809249-37-3 | Human | R & D |
| Remimazolam | N Nervous System | 308242-62-8 | Human | R & D |
| Revefenacln | R Respiratory System | 864750-70-9 | Human | R & D |
| Ribociclib Succinate | L Antineoplastic and Immunomodulating Agents | 1374639-75-4 | Human | R & D |
| Rifabutin | J Antiinfectives for Systemic Use | 72559-06-9 | Human | R & D |
| Rifaximin | A Alimentary Tract and Metabolism D Dermatologicals | 80621-81-4 | Human | R & D |
| Rilpivirine | J Antiinfectives for Systemic Use | 500287-72-9 | Human | R & D |
| Rilpivirine HCl | J Antiinfectives for Systemic Use | 700361-47-3 | Human | R & D |
| Rimegepant | N Nervous System | 1289023-67-1 | Human | R & D |
| Rimegepant Sulphate | N Nervous System | 1374024-48-2 | Human | R & D |
| Riociguat | C Cardiovascular System | 625115-55-1 | Human | R & D |
| Riociguat Modification-I | C Cardiovascular System | 625115-55-1 | Human | R & D |
| Ripasudil | S Sensory Organs | 223645-67-8 | Human | R & D |
| Ripretinib | L Antineoplastic and Immunomodulating Agents | 1442472-39-0 | Human | R & D |
| Risdiplam | M Musculo-Sekeletal System | 1825352-65-5 | Human | R & D |
| Ritlecitinib | n.a. | 1792180-81-4 | Human | R & D |
| Ritonavir | J Antiinfectives for Systemic Use | 155213-67-5 | Human | R & D |
| Ritonavir Hot Melt Extrudate | J Antiinfectives for Systemic Use | n.a. | Human | R & D |
| Rivaroxaban | B Blood and Blood Forming Organs | 366789-02-8 | Human | R & D |
| Rocuronium Br | M Musculo-Sekeletal System | 119302-91-9 | Human | R & D |
| Roflumilast | R Respiratory System | 162401-32-3 | Human | R & D |
| Ropivacaine HCl | N Nervous System | 132112-35-7 | Human | R & D |
| Rosuvastatin | C Cardiovascular System | 287714-41-4 | Human | R & D |
| Rotigotine | N Nervous System | 99755-59-6 | Human | R & D |
| Rotigotine Form II | N Nervous System | 99755-59-6 | Human | R & D |
| Roxadustat | B Blood and Blood Forming Organs | 808118-40-3 | Human | R & D |
| Rucaparib Camsylate | L Antineoplastic and Immunomodulating Agents | 1859053-21-6 | Human | R & D |
| Rufinamide | N Nervous System | 106308-44-5 | Human | R & D |
| Rupatadine Fumarate | R Respiratory System | 182349-12-8 | Human | R & D |
| Ruxolitinib | L Antineoplastic and Immunomodulating Agents | 941678-49-5 | Human | R & D |
| Ruxolitinib Phosphate | L Antineoplastic and Immunomodulating Agents | 1092939-17-7 | Human | R & D |
| Sacubitril | C Cardiovascular System | 149709-62-6 | Human | R & D |
| Sacubitril Sodium | C Cardiovascular System | 149690-05-1 | Human | R & D |
| Sacubitril Valsartan | C Cardiovascular System | 936623-90-4 | Human | R & D |
| Sacubitril Valsartan Complex | C Cardiovascular System | 936623-90-4 | Human | R & D |
| Sacubitril Valsartan Trisodium Hemipentahydrate | C Cardiovascular System | 149709-62-6 | Human | R & D |
| Safinamide | N Nervous System | 133865-89-1 | Human | R & D |
| Safinamide Methanesulfonate | N Nervous System | 202825-46-5 | Human | R & D |
| Samidorphan | N Nervous System | 852626-89-2 | Human | R & D |
| Sapropterin | A Alimentary Tract and Metabolism | 62989-33-7 | Human | R & D |
| Saxagliptin | A Alimentary Tract and Metabolism | 361442-04-8 | Human | R & D |
| Saxagliptin H2O | A Alimentary Tract and Metabolism | 945667-22-1 | Human | R & D |
| Saxagliptin HCl | A Alimentary Tract and Metabolism | 709031-78-7 | Human | R & D |
| Saxagliptin HCl 2H2O | A Alimentary Tract and Metabolism | 1073057-20-1 | Human | R & D |
| Scopolamine Butylbromide | A Alimentary Tract and Metabolism | 149-64-4 | Human | R & D |
| Selenous Acid | D Dermatologicals | 7783-00-8 | Research | R & D |
| Selexipag | B Blood and Blood Forming Organs | 475086-01-2 | Human | R & D |
| Selexipag Form I | B Blood and Blood Forming Organs | 475086-01-2 | Human | R & D |
| Selinexor | L Antineoplastic and Immunomodulating Agents | 1393477-72-9 | Human | R & D |
| Selpercatinib | L Antineoplastic and Immunomodulating Agents | 2152628-33-4 | Human | R & D |
| Selumetinib | L Antineoplastic and Immunomodulating Agents | 606143-52-6 | Human | R & D |
| Selumetinib Sulphate | L Antineoplastic and Immunomodulating Agents | 943332-08-9 | Human | R & D |
| Semaglutide | A Alimentary Tract and Metabolism | 910463-68-2 | Human | R & D |
| Semaglutide Acetate | A Alimentary Tract and Metabolism | 910463-68-2 | Human | R & D |
| Sertraline HCl Form I | N Nervous System | 79559-97-0 | Human | R & D |
| Setmelanotide Acetate | A Alimentary Tract and Metabolism | 920014-72-8 | Human | R & D |
| Sildenafil Citrate | G Genito Urinary System and Sex Hormones | 171599-83-0 | Human | R & D |
| Silodosin | G Genito Urinary System and Sex Hormones | 160970-54-7 | Human | R & D |
| Simvastatin | C Cardiovascular System | 79902-63-9 | Human | R & D |
| Siponimod | L Antineoplastic and Immunomodulating Agents | 1230487-00-9 | Human | R & D |
| Siponimod Fumarate | L Antineoplastic and Immunomodulating Agents | 1234627-85-0 | Human | R & D |
| Sirolimus | S Sensory Organs L Antineoplastic and Immunomodulating Agents | 53123-88-9 | Human | R & D |
| Sitagliptin | A Alimentary Tract and Metabolism | 486460-32-6 | Human | R & D |
| Sitagliptin HCl | A Alimentary Tract and Metabolism | 486459-71-6 | Human | R & D |
| Sitagliptin Phosphate | A Alimentary Tract and Metabolism | 654671-77-9 | Human | R & D |
| Sitagliptin Phosphate Anhydrous | A Alimentary Tract and Metabolism | 654671-78-0 | Human | R & D |
| Sitagliptin Phosphate H2O | A Alimentary Tract and Metabolism | 654671-77-9 | Human | R & D |
| Sodium Cromolyn / Cromoglycate | n.a. | n.a. | Human | R & D |
| Sofosbuvir | J Antiinfectives for Systemic Use | 1190307-88-0 | Human | R & D |
| Sofpironium Br | n.a. | 1628106-94-4 | Human | R & D |
| Solithromycin | J Antiinfectives for Systemic Use | 760981-83-7 | Human | R & D |
| Solriamfetol HCl | N Nervous System | 178429-65-7 | Human | R & D |
| Sotagliflozin | A Alimentary Tract and Metabolism | 1018899-04-1 | Human | R & D |
| Sotorasib | L Antineoplastic and Immunomodulating Agents | 2296729-00-3 | Human | R & D |
| Sparsentan | n.a. | 254740-64-2 | Human | R & D |
| Spironolactone | C Cardiovascular System | 52-01-7 | Human | R & D |
| Staurosporine | n.a. | 62996-74-1 | Research | R & D |
| Succinylcholine Choride | n.a. | 71-27-2 | Human | R & D |
| Sucroferric Oxyhydroxide | V Various | 20344-49-4 | Human | R & D |
| Sugammadex | V Various | 343306-71-8 | Human | R & D |
| Sugammadex Sodium | V Various | 343306-79-6 | Human | R & D |
| Sulfoxide | M Musculo-Sekeletal System | 120-62-7 | Research | R & D |
| Sunitinib Malate | M Musculo-Sekeletal System | 341031-54-7 | Human | R & D |
| Suvorexant | N Nervous System | 1030377-33-3 | Human | R & D |
| Tadalafil | G Genito Urinary System and Sex Hormones | 171596-29-5 | Human | R & D |
| Tafamidis | N Nervous System | 594839-88-0 | Human | R & D |
| Tafamidis Meglumine | N Nervous System | 951395-08-7 | Human | R & D |
| Talazoparib Tosylate | L Antineoplastic and Immunomodulating Agents | 1373431-65-2 | Human | R & D |
| Tamoxifen Citrate | L Antineoplastic and Immunomodulating Agents | 54965-24-1 | Human | R & D |
| Tamsulosin HCl | G Genito Urinary System and Sex Hormones | 106463-17-6 | Human | R & D |
| Tapentadol HCl | N Nervous System | 175591-09-0 | Human | R & D |
| Tavaborole | D Dermatologicals | 174671-46-6 | Human | R & D |
| Tazemetostat HBr | L Antineoplastic and Immunomodulating Agents | 1467052-75-0 | Human | R & D |
| Teduglutide | A Alimentary Tract and Metabolism | 197922-42-2 | Human | R & D |
| Teduglutide Acetate | A Alimentary Tract and Metabolism | 197922-42-2 | Human | R & D |
| Tegaserod | A Alimentary Tract and Metabolism | 145158-71-0 | Human | R & D |
| Tegaserod Maleate | A Alimentary Tract and Metabolism | 189188-57-6 | Human | R & D |
| Telmisartan | C Cardiovascular System | 144701-48-4 | Human | R & D |
| Telotristat | A Alimentary Tract and Metabolism | 1033805-22-9 | Human | R & D |
| Telotristat Etiprate | A Alimentary Tract and Metabolism | 1137608-69-5 | Human | R & D |
| Tenapanor | A Alimentary Tract and Metabolism | 1234365-97-9 | Human | R & D |
| Tenapanor HCl | A Alimentary Tract and Metabolism | 1234365-97-9 | Human | R & D |
| Teneligliptin HBr H2O | A Alimentary Tract and Metabolism | 1572583-29-9 | Human | R & D |
| Tenofovir | J Antiinfectives for Systemic Use | 147127-20-6 | Human | R & D |
| Tenofovir Alafenamide Fumarate | J Antiinfectives for Systemic Use | 1392275-56-7 | Human | R & D |
| Tenofovir Alafenamide Hemifumarate | J Antiinfectives for Systemic Use | 1392275-56-7 | Human | R & D |
| Tenofovir Alafenamide Maleate | J Antiinfectives for Systemic Use | 379270-38-9 | Human | R & D |
| Tenofovir Disoproxil Fumarate | J Antiinfectives for Systemic Use | 202138-50-9 | Human | R & D |
| Tepotinib | L Antineoplastic and Immunomodulating Agents | 1100598-32-0 | Human | R & D |
| Teriflunomide | L Antineoplastic and Immunomodulating Agents | 108605-62-5 | Human | R & D |
| Tesetaxel | n.a. | 333754-36-2 | Human | R & D |
| Tezacaftor | R Respiratory System | 1152311-62-0 | Human | R & D |
| Thiocolchicoside | M Musculo-Sekeletal System | 602-41-5 | Human | R & D |
| Thiothixene | N Nervous System | 3313-26-6 | Human | R & D |
| Tiagabine HCl | N Nervous System | 115103-54-3 | Human | R & D |
| Ticagrelor | B Blood and Blood Forming Organs | 274693-27-5 | Human | R & D |
| Ticagrelor Form II | B Blood and Blood forming Organs | 274693-27-5 | Human | R & D |
| Tigecycline HCl | J Antiinfectives for Systemic Use | 197654-04-9 | Human | R & D |
| Tildipirosin | J Antiinfectives for Systemic Use | 328898-40-4 | Vet | R & D |
| Tiotropium Br | R Respiratory System | 136310-93-5 | Human | R & D |
| Tipiracil | L Antineoplastic and Immunomodulating Agents | 183204-74-2 | Human | R & D |
| Tirbanibulin | D Dermatologicals | 897016-82-9 | Human | R & D |
| Tivozanib | L Antineoplastic and Immunomodulating Agents | 475108-18-0 | Human | R & D |
| Tivozanib HCl H2O | L Antineoplastic and Immunomodulating Agents | 682745-41-1 | Human | R & D |
| Toceranib | L Antineoplastic and Immunomodulating Agents | 356068-94-5 | Vet | R & D |
| Tofacitinib | L Antineoplastic and Immunomodulating Agents | 477600-75-2 | Human | R & D |
| Tofacitinib Citrate | L Antineoplastic and Immunomodulating Agents | 540737-29-9 | Human | R & D |
| Tolvaptan | C Cardiovascular System | 150683-30-0 | Human | R & D |
| Topiramate | N Nervous System | 97240-79-4 | Human | R & D |
| Tramadol HCl | N Nervous System | 36282-47-0 | Human | R & D |
| Trametinib Dimethyl | L Antineoplastic and Immunomodulating Agents | 1187431-43-1 | Human | R & D |
| Trametinib Dimethyl Sulfoxide | L Antineoplastic and Immunomodulating Agents | 1187431-43-1 | Human | R & D |
| Tranexamic Acid | B Blood and Blood Forming Organs | 1197-18-8 | Human | R & D |
| Trazodone | N Nervous System | 19794-93-5 | Human | R & D |
| Trazodone HCl | N Nervous System | 25332-39-2 | Human | R & D |
| Trelagliptin | n.a. | 865759-25-7 | Human | R & D |
| Trenbolone Acetate | n.a. | 10161-33-8 | Vet | R & D |
| Trientine 2HCl | A Alimentary Tract and Metabolism | 38260-01-4 | Human | R & D |
| Trifarotene | D Dermatologicals | 895542-09-3 | Human | R & D |
| Trifluridine | S Sensory Organs | 70-00-8 | Human | R & D |
| Trilaciclib | V Various | 1374743-00-6 | Human | R & D |
| Trilaciclib 2HCl | V Various | 2519335-12-5 | Human | R & D |
| Triptorelin Acetate | L Antineoplastic and Immunomodulating Agents | 140194-24-7 | Human | R & D |
| Tucatinib | L Antineoplastic and Immunomodulating Agents | 937263-43-9 | Human | R & D |
| Ubrogepant | N Nervous System | 1374248-77-7 | Human | R & D |
| Umbralisib | L Antineoplastic and Immunomodulating Agents | 1532533-67-7 | Human | R & D |
| Umbralisib Tosylate | L Antineoplastic and Immunomodulating Agents | 1532533-72-4 | Human | R & D |
| Umeclidinium Br | R Respiratory System | 869113-09-7 | Human | R & D |
| Umifenovir HCI | J Antiinfectives for Systemic Use | 131707-23-8 | Human | R & D |
| Upadacitnib | L Antineoplastic and Immunomodulating Agents | 1310726-60-3 | Human | R & D |
| Urapidil HCl H2O | C Cardiovascular System | 64887-14-5 | Human | R & D |
| Ursodeoxycholic Acid | A Alimentary Tract and Metabolism | 128-13-2 | Human | R & D |
| Vadadustat | B Blood and Blood Forming Organs | 1000025-07-9 | Human | R & D |
| Valacyclovir | J Antiinfectives for Systemic Use | 124832-26-4 | Human | R & D |
| Valbenazine | N Nervous System | 1025504-45-3 | Human | R & D |
| Valbenazine Tosylate | N Nervous System | 1639208-54-0 | Human | R & D |
| Valsartan / Sacubitril | C Cardiovascular System | 137862-53-4 | Human | R & D |
| Varenicline | N Nervous System S Sensory Organs | 249296-44-4 | Human | R & D |
| Varenicline Tartrate | N Nervous System S Sensory Organs | 375815-87-5 | Human | R & D |
| Vecuronium HBr | M Musculo-Sekeletal System | 50700-72-6 | Human | R & D |
| Velpatasvir | J Antiinfectives for Systemic Use | 1377049-84-7 | Human | R & D |
| Vemurafenib | L Antineoplastic and Immunomodulating Agents | 1029872-54-5 | Human | R & D |
| Venetoclax | L Antineoplastic and Immunomodulating Agents | 1257044-40-8 | Human | R & D |
| Venglustat | n.a. | 1401090-53-6 | Human | R & D |
| Vericiguat | C Cardiovascular System | 1350653-20-1 | Human | R & D |
| Vibegron | G Genito Urinary System and Sex Hormones | 1190389-15-1 | Human | R & D |
| Vilanterol | R Respiratory System | 503068-34-6 | Human | R & D |
| Vilanterol Trifenatate | R Respiratory System | 503070-58-4 | Human | R & D |
| Vilazidone | N Nervous System | 163521-12-8 | Human | R & D |
| Vildaglibtin | A Alimentary Tract and Metabolism | 274901-16-5 | Human | R & D |
| Viloxazine | N Nervous System | 46817-91-8 | Human | R & D |
| Viloxazine HCl | N Nervous System | 46817-91-8 | Human | R & D |
| Vismodegib | L Antineoplastic and Immunomodulating Agents | 879085-55-9 | Human | R & D |
| Voclosporin | L Antineoplastic and Immunomodulating Agents | 515814-01-4 | Human | R & D |
| Vonoprazan | A Alimentary Tract and Metabolism | 881681-01-2 | Human | R & D |
| Vonoprazan Fumarate | A Alimentary Tract and Metabolism | 1260141-27-2 | Human | R & D |
| Vortioxetine | N Nervous System | 508233-74-7 | Human | R & D |
| Vortioxetine HBr | N Nervous System | 960203-27-4 | Human | R & D |
| Voxelotor | B Blood and Blood Forming Organs | 1446321-46-5 | Human | R & D |
| Warfarin Sodium | B Blood and Blood Forming Organs | 129-06-6 | Human | R & D |
| Zanubrutinib | L Antineoplastic and Immunomodulating Agents | 1691249-45-2 | Human | R & D |
| Zolmitriptan | N Nervous System | 139264-17-8 | Human | R & D |
| Zuranolone | N Nervous System | 1632051-40-1 | Human | R & D |
Disclaimer: for more details, please go here
Humans, animals, and the environment – our health is connected
Veterinary APIs that improve the health of companion and farm animals
TIEFENBACHER API + INGREDIENTS offers a wide variety of products for companion and farm animals with the highest demand concerning quality and reliability.
We believe that when animals are healthy, humans are healthier too – therefore we are committed to improve both animal and human health. With roots in Europe, and more than 60 years of pharmaceutical expertise, our animal health division brings solutions to the market that benefit the well-being and productivity of our animals. Our sourcing capability is built on long standing partnerships with GMP-manufacturers and an ever expanding global network of suppliers in Europe + Asia – with their support we always aim to provide a reliable solution – dedicated to your specific requirements and distributed following GDP (Good Distribution Practices).
Tiefenbacher API + Ingredients: Local Knowledge with worldwide Expertise
Our value seal: Offering our customers high-quality API-solutions
Each year our APIs positively impact millions of patients’ lives as the same quality active ingredients are used by both major innovative brands and generic companies in the industry. Our exceptional and extensive know-how enables us to tailor our products and services specifically to your needs.
Better Access
Best possible APIs
We source and offer a proven portfolio of high-quality raw materials (human + veterinary) that consistently assures safety and reliability along the whole API value chain.
Better Quality
Quality comes first
We provide a range of services to ensure all global regulatory needs and approvements such as GMP/GDP along with the documentations that are required for a regulated market.
Better Supply
Reliable API distribution
We deliver high-quality APIs wherever and whenever required: Reliably delivered and tailor-made solutions according to your specific needs.
News Tiefenbacher Group
We have always been purpose-driven to make a difference with our products and services – for the benefit of patients worldwide. What’s new is that we want to talk more about it and share stories about the impact we make. So please have a look and learn more about how we, TIEFENBACHER GROUP, are pioneering healthcare – and contribute to people for a better tomorrow.
News Tiefenbacher Group
We have always been purpose-driven to make a difference with our products and services – for the benefit of patients worldwide. What’s new is that we want to talk more about it and share stories about the impact we make. So please have a look and learn more about how we, TIEFENBACHER GROUP, are pioneering healthcare – and contribute to people for a better tomorrow.
Successful Approval of manufacturing and laboratory facilities by Saudi Food and Drug Authority
New site approval! We are happy to announce that our manufacturing and laboratory facilities for oral solids at AET Laboratories in Hyderabad (India) have been successfully registered by…
TIEFENBACHER GROUP IS COMMITTED TO BECOMING CLIMATE NEUTRAL
We are pleased to share that TIEFENBACHER GROUP is committed to becoming climate neutral by the end of 2025*. As a value-driven healthcare company, dedicated to improving the life of…
Tiefenbacher API + Ingredients: Local Knowledge with worldwide Expertise
Global sourcing and distributing of high-quality Active Pharmaceutical Ingredients (APIs) with value-added services
Contact – Tiefenbacher API + Ingredients
Contact us for further information around our high-quality raw materials (Human + Veterinary) and value-added services. With more than 50 years of expertise in Active Pharmaceutical Ingredients (APIs), and a strong track record of quality and regulatory excellence, we are offering solutions along the whole API value chain – and accelerating your path to market. Please contact us by filling out the contact form below and clicking “Send message”, or directly send an email to info@tifi-api.eu. TIEFENBACHER API + INGREDIENTS will follow up with you personally as soon as possible.
TIEFENBACHER API + INGREDIENTS GMBH & CO. KG
Van-der-Smissen-Strasse 1-2
22767 Hamburg
Germany
Phone: +49 40 – 36 09 18 – 0
Fax: +49 40 – 36 09 18 – 222
Mail: info@tifi-api.eu
